apparatus and system for remodeling a therapeutic zone in the tissue underlying a mucosal epithelium

专利摘要:
APPARATUS AND SYSTEM FOR REMODELING A THERAPEUTIC ZONE IN THE TISSUE UNDERLYING A MUCOSAL EPITHELIUM OF FEMALE GENITAL TISSUE, AND, METHOD FOR 5 DETERMINING IF AN ENERGY DISTRIBUTION ELEMENT FOR A TREATMENT TIP FOR AN ENERGY DEVICE WITH A ENERGY DEVICE IN A ENERGY DEVICE TISSUE TO BE TREATED This invention relates in general to apparatus and methods for tightening female genital tissue, heating the target connective tissue with radiant energy, while cooling the mucosal epithelial surface over the target tissue to protect it from heat . Modalities include a handle and treatment tip that have both an energy distribution element and a cooling mechanism. The handle can be a handle for use in any hand that allows control even during rotation and treatment maneuver around the genital opening. The device or system may also include an integrated controller, which can confirm tissue contact without applying RF energy, based only on the temperature of the applicator and the time since the last application of energy by the applicator.
公开号:BR112012006059B1
申请号:R112012006059-7
申请日:2010-09-16
公开日:2020-12-29
发明作者:Jonathan B. Parmer；Ian F. Smith；Chunchih Cheng；Patrick Karl Howe；Sean Yasuo Sullivan；Jerome Jackson；Stanley Levy；Sherree Leigh Lucas；Steven Marc Lopez
申请人:Viveve, Inc；
IPC主号:

专利说明:

RELATED REQUESTS
[001] This patent application claims priority for U.S. provisional patent application 61/243686, filed on September 18, 2009, entitled "VAGINAL REMODELING DEVICE AND METHODS".
[002] This patent application may also be related to the pending US patent application Serial No. 11 / 704.067, filed on 7/2/2007, and entitled "VAGINAL REMODELING DEVICE AND METHODS", which claims priority for the provisional application US no. 60 / 743,247, by Parmer, filed on February 7, 2006, and entitled "Vaginal rejuvenation treatment device and methods". The disclosures of all these patent applications are hereby incorporated by reference in their entirety. INCORPORATION BY REFERENCE
[003] As a general matter, all publications and patent applications identified herein are incorporated by the reference in their entirety as if each individual publication or patent application was individually indicated to be incorporated by the reference. FIELD OF THE INVENTION
[004] This invention relates in general to methods, devices and systems to remodel tissue of the vagina and vulva, as well as by the application of radiant energy. BACKGROUND OF THE INVENTION
[005] The vagina is made up of three layers: a stratified squamous epithelial tissue mucosa; the submucosa or lamina propria, containing vascularized connective tissue; and a deeper muscle, containing smooth muscle. Collagen molecules are produced by cells residing in these tissues that synthesize three polypeptide chains that wrap to form a triple helix. Collagen is a major type of fibrous protein that is a basic structural element of connective tissue, tendon, cartilage and bone. Each of the collagen chains is approximately 1,000 units of amino acid in length, with glycine regularly using every third unit, and proline and hydroxyproline using very frequently. Cross-linking occurs between the sides, not at the ends, of collagen molecules and is coupled with the amino acid composition to give collagen its great resistance. Tightening of collagen tissue occurs in a direction parallel to an axis of collagen fibers.
[006] The phenomenon of collagen thermal contraction begins with a denaturation of the triple helix of the collagen molecule. Partial denaturation of collagen tissue results in a contraction of collagen-rich spaces and provides a "tightening" effect on the overlying tissue. Relevant patents for the collagen denaturation and exploitation aspects of this for medical or cosmetic purposes include Knowlton US patents 5,919,219 for "Method for Controlled Contraction of Colagen Tissue Using RF Energy" and 5,775,753 for Knowlton for "Method for Controlled" Contraction of Colagen Tissue "; and Fellner's U.S. Patent 5,143,063 to "Method of Removing Adipose Tissue".
[007] Additionally, published patents and patent applications include U.S. patent 6,350,276 to Knowlton for "Tissue Remodeling Apparatus Containing Cooling Fluid"; U.S. Patent 6,387,380 to Knowlton of "Apparatus for Controlled Contraction of Tissue of Colagen"; U.S. Patent 6,425,912 to Knowlton's "Method and Apparatus for Modifying Skin Surface and Soft Tissue Structure"; U.S. patent 6,453,202 to Knowlton of "Apparatus for Tissue Remodeling"; U.S. Pub 2002/0049483 to Knowlton's "Fluid Delivery Apparatus"; U.S. Pub 2003/0212393 to Knowlton's "hand piece with RD Electrode and Non-Volatile Memory"; U.S. Pub 2003/0236487 to Knowlton's "Method for Treatment of Tissue with Feedback"; and U.S. Pub 2004/0000316 by Knowlton of "Methods for creating Tissue Effect Using Electromagnetic Energy and a Reverse Thermal Gradient".
[008] The vaginal tissue of women is stretched during normal birth; at least some of the effects of stretching are permanent and many women have long-term medical consequences. Some consequences include physical problems, such as uterine prolapse, cystoceles, urethroceles, enteroceles, rectoceles, stress urinary incontinence, bowel movement problems, for which surgical options are available. Some consequences can include sexual aspects, which can result from excessive loosening of the vagina and its opening, the opening. Such laxity typically occurs with the first normal delivery, and laxity tends to increase with subsequent normal deliveries. This effect of laxity in this region may include less pressure and friction during sexual intercourse and, as a result, less sexual pleasure for women and their conjugal partners. Some surgical options can be exercised in an attempt to alleviate these problems, but surgical approaches can carry a risk of abrasion that is completely counterproductive in relation to the desired result. More generally, these surgical approaches are not highly popular due to the risks associated with an invasive procedure, in a sensitive area, especially when such procedures are considered medically optional.
[009] Systems and devices known to treat the vagina are less than ideal, including those that use radiant energy to modify collagen. In particular, known systems are not optimized for handling the device, including the energy applicator (eg, handle, applicator, etc.) and the cooling of the treated tissue. Furthermore, existing systems cannot ideally regulate contact with the patient's tissue. Finally, known systems have not proved to be simple to use, light and intuitive. Here, systems, devices and methods of using them to remodel and treat the mucosal surfaces of the vagina, introitus and vulva are described.
[010] Thus, there is a need for effective approaches to treat a loose vagina and introitus with a non-invasive procedure, and particularly for systems and devices that simplify and improve treatment, particularly when applying RF energy. Thus, an objective of the present invention is to provide systems (including apparatus and devices) and methods for corrective or restorative remodeling of the mucosal surfaces of the vagina, introitus and vulva. SUMMARY OF THE INVENTION
[011] Devices and systems for remodeling target tissues, including the lamina propria and muscle, underlying the mucosal epithelium of female genital tissue, and methods for remodeling tissue using these devices and systems are described herein. One of such devices typically includes a handpiece and a treatment tip, and can form part of a system including the device, a coolant source, and an electronic system (for example, control) for controlling the handpiece and tip as well as a power supply. Modalities of the treatment tip may include a connector portion, which connects the tip to the handpiece, an intermediate section (which can be narrowed), and a distal portion that includes an energy distribution element. The treatment tip may also include a lumen or housing that defines an internal space. The internal space typically accommodates a cooling system, with a lumen to transfer a coolant (eg, a coolant), and applicators (eg, nozzles) that are adapted to spray coolant on the inner side of the power distribution element , thus cooling it, such a cooled element, in turn, cooling an epithelial surface of the genital mucosa through contact. The device may also include a refrigerant removal line for removing or discharging the refrigerant.
[012] The devices described here can be configured to match a handle (handpiece). The handle can be lengthened so that it can be picked up and manipulated along the same axis as the tip, for insertion into the vaginal region. The handle can be adapted to include quick-connect couplings for the tip distally (for example, electrical couplings, in-line refrigerant couplings, off-line refrigerant couplings, sensor couplings, etc.). The proximal end of the handle may include a wire, cable, or other connector for connection to the controller and / or power supply. In some variations, the handle is configured to be picked up with both hands (for example, two hands). The handle can also be configured so that it does not include a control (switch, button, etc.) to activate the RF energy distribution; instead, the RF energy distribution can be done by a foot switch or another handless switch. This can increase the applicator's ease of handling, even as it is rotated and repositioned to reach the target tissue within the body.
[013] The system can also be configured so that the refrigerant is discharged a substantial distance from the patient (for example, away from the handle, at the end of the wire / cable). In some variations, the refrigerant is connected to a recycler for recycling or disposal; in other variations, the refrigerant is eliminated externally.
[014] The power distribution element can be configured as a radiofrequency, microwave, or ultrasound delivery element. Some particular modalities include capacitively coupled RF electrodes, which can be monopolar or bipolar. Modalities based on monopolar RF electrode may comprise a conductive pad to serve as a return electrode. Modes based on bipolar RF may include one or more pairs of electrodes. The electrodes can additionally comprise thermal sensors that provide feedback control based on local temperature, and can additionally comprise EEROM chips that identify the type of treatment tip or that transfer configuration parameters from the electrode to the handpiece, or to the electronics bigger.
[015] The energy distribution element and the treatment tip can also be adapted to optimize contact with the genital epithelial surface, when contact and capacitive coupling is occurring between the tip and an epithelial contact site. Ideal contact can refer to a contact that optimizes the distribution of energy in the target tissue so that it is generally uniform on the surface of the contact site, preferably without significant distortion along the edges of the contact site. Non-uniform energy delivery also does not serve the remodeling process, and may additionally present a risk of damage to the mucosal epithelium. Such adaptive configurations may include a laterally mounted configuration of the energy distribution element, the face of the energy distribution element being substantially parallel with respect to the linear axis of the treatment tip. Other adaptive configurations may include a narrow middle section from the proximal tip to the distal portion. This configuration can allow the energy distribution element in the distal portion of the tip to protrude outward or forward from its surrounding support structure, thus allowing contact between the energy distribution element and the mucosal epithelium to be more precise, deliberate and visible, and that the level of contact pressure is better controlled by the doctor.
[016] The dimensions and configuration of the power distribution element can be adapted for optimal contact, particularly with the vaginal wall. The width of the power distribution element is between 0.75 and 1.25 cm. Such a width is sufficient to fit the curved wall of the vagina in a way that is sufficiently flat and parallel to the point that the quality of contact across the face of the energy distribution element is substantially the same, without increased pressure, more intimate contact , or distortion along the edges of the element. An intimate contact like this allows a uniform delivery of energy to the underlying target tissue. In some embodiments, the face of the energy distribution element is radially curved (with respect to the longitudinal axis of the tip) in the width of the element in order to create an arc of up to 30 degrees. Such curvature is also adapted to make parallel contact with the vaginal wall. An element about 1 cm wide, for modalities of the invention, requires about 10 contact locations to radially treat a 300 degree arc inside a vagina, so a 30 degree arc allows a good fit in the curve of the vaginal wall and thus provides a uniform delivery of energy to the target tissue.
[017] In typical embodiments, the length of the power distribution element is about 1 to about 3 cm in length; in other modalities it can be up to about 4 cm long. This is a length well adapted to treat the inferior aspect of the vagina, where the treatment by the method comprises contacting the vaginal epithelium in a region that extends from the introitus to a position about 3 to 4 cm into the introitus. In some embodiments of the invention, the method can be practiced with a single row of parallel contact sites immediately within the introitus. In other modalities, the method may include deeper rows, or rows that overlap an initial row, while maintaining the contact locations on the lower portion of the vagina.
[018] In general, the power distribution tip of the device is cooled. The tip can be internally cooled; for example, a housing (cavity) inside the tip can be cooled to cool the applicator tip. Cooling can be carried out by applying a cooling element (eg refrigerant) inside the housing. For example, the housing can be cooled by spraying a coolant through one or more nozzles inside the housing on the rear (inner side) of the power distribution surface. The blast coolant pattern can be optimized. It is desirable to apply completely and quickly in a highly controllable manner. The temperature control of the applicator tip allows the applied energy to be controlled, since the fabric temperature can also be regulated. Rapid cooling is preferable, so that the device can be used efficiently and quickly. However, it is also beneficial to save refrigerant, and to control the refrigerant path in order to allow the most efficient use of the manual applicator. Thus, devices configured to balance refrigerant conservation with quick and complete cooling of the applicator are described here. For example, devices can be configured to have a plurality of nozzles with a spray pattern that covers most of one side of the applicator surface (for example, the power distribution surface). The number of nozzles can be minimized, further maximizing the distribution of the spray pattern in the space of the internal tip. In addition, the applicator tip and handle region may include a refrigerant distribution channel and a refrigerant return channel that includes one or more seals and quick release / quick release connectors. The handgrip region may also include one or more refrigerant delivery channels and refrigerant return channels that match the refrigerant delivery tip and refrigerant return channels. The refrigerant return path can extend proximally through the device and can exit to a delivery location that is located proximally to the patient. For example, the refrigerant return channel can extend through the cabling or connector at the proximal end of the applicator for proximal ventilation. In some variations, the refrigerant return channel couples with a refrigerant recycler to capture the refrigerant. The refrigerant recycler can be configured to collect the refrigerant for later reuse and / or disposal, or it can include refrigerant recycling components (eg, compressors, etc.).
[019] The handle and tip (applicator) can also include one or more lamps. Lamps (for example, indicator lamps) can help guide the operation of the device, including attaching the tip, aligning the device, aligning the tip with the handle, etc. For example, in some variations, the handle includes a lamp surrounding the proximal or distal end of the device that can indicate the orientation of the handle. In some variations, the indicator lamps may indicate that the tip is attached to the handle, and / or the state of the tip (cooled and ready for use, etc.). The handle may include one or more controls, such as a button or switch, to operate the device for applying power to the power distribution element.
[020] As mentioned, the tip can be configured to be quickly connected and / or replaced on the handle. Thus, the handle tip and region can be modular. In some variations, the tip and handle are integrally (for example, permanently) connected. In other variations, the tip can be replaced between procedures, while the same handle is reused. Thus, the tip and handle can be adapted for fast and accurate connection. Thus, the tip may include an electrical connector to connect to a complementary connector on the handle to drive the power distribution element. The tip and handle can also include sealing connectors to connect refrigerant delivery and return lines. The connectors can be attached by pressure (for example, friction fitting) which can be securely attached and then removed. The tip can be switched on the handle so that it can attach only in the proper orientation or configuration. In some variations, the device may include an indicator that indicates when the tip is properly attached (for example, so that the refrigerant lines are sealed, etc.).
[021] Methods for remodeling a therapeutic tissue zone into target tissue of female genitalia are also described. The target tissue is disposed immediately below the mucosal epithelium of genital tissues, and includes the lamina propria, a connective tissue that includes collagen in the extracellular space, and the muscle, which includes smooth muscle. The target range of modalities of the invention does not include deeper tissue, such as endopelvic fascia.
[022] The anatomical areas of the female genitalia treated by the modality of the invention include the vulva and the vagina, and the introitus, the opening of the vagina. The vulva includes tissue that radiates out of the introitus to the Hart line, where the mucosal epithelium gives way to the skin on the outer surface of the labia minora. With more specific regard to the vagina, modalities of the method include treating the lower portion of the vagina, a portion that extends from the introitus to a location of about 2 cm to about 4 cm into the introitus, in other modalities, the location it can extend inward to about 6 cm. With regard to the circumference of the inner wall of the vagina, a clock position reference scheme is useful. The urethra is located close to the anterior wall of the vagina, the location of the vaginal wall closest to the urethra and the urethral opening can be considered 12 hours. With this reference point, the target tissue of modalities of the invention includes the arc of approximately 300 degrees between 1 hour and 11 hours. Modalities of the invention do not include treating the arc of approximately 60 degrees between 11 hours and 1 hour because the practice of this invention is not aimed at the tissue in the vicinity of the urethra.
[023] Modalities of the method include heating the target zone with radiant energy, typically radiofrequency (RF) energy, but other modalities may use microwave or ultrasound energy. The method includes putting the mucosal epithelium in contact with a treatment tip that has an energy distribution element and a cooling mechanism. By distributing energy in the tissue during cooling of the epithelial surface, a reverse thermal gradient can be created. RF energy penetrates the cooled epithelium and the underlying target tissue, and heats the tissue.
[024] A tissue zone that is heated within the target tissues to a plateau level, that is, to a therapeutic temperature that causes remodeling, is called a therapeutic zone. Not all tissue within the target tissue necessarily reaches this level of heat. In some cases, cooling of the treatment tip can penetrate the target tissue and, in this situation, the presence of cooled tissue can have an effect on the therapeutic zone, moving it deeper into the target tissue, for example, or restricting its volume.
[025] The energy delivered by the treatment tip can heat the target tissue to a temperature as high as about 80 ° C in some modalities, the therapeutic temperature can vary between about 45 ° C and about 80 ° C. In other embodiments, the therapeutic temperature can vary between about 50 ° C and about 75 ° C in still other embodiments, the therapeutic temperature can vary between about 55 ° C and about 70 ° C. The heating can be subjected to feedback control during a treatment procedure, in order to maintain the temperature in a predetermined temperature range. Feedback can be provided by one or more sensors, including thermal sensors (eg thermistors) and impedance displays. The treatment tip can cool the epithelium to a temperature between about 0 ° C and about 10 ° C. A reverse thermal gradient, in this way, can be represented by a low temperature between about 0 ° C and about 10 ° C in the mucosal epithelium, and a high temperature between 45 ° C and about 80 ° C in the target tissue. During a typical procedure, according to the modalities of the invention, any heating period is accompanied by cooling; however, cooling can also precede heating, and follow heating.
[026] Treatment methods include bringing the treatment tip into contact with a contact site in the mucosal epithelium. The contact location conforms to the dimensions of the treatment surface of the treatment tip. During the course of a single treatment, such as a visit to the doctor's office, for example, typically a plurality of contact locations can be treated. During a procedure, a single contact point can be contacted multiple times. The total sum of mucosal contact sites comprises a treatment area. An area like this, comprising multiple contact locations, can be engraved on a grid. The method can be applied on more than one occasion; a patient can return to the doctor at a later date when the effects of a previous treatment can be assessed and treatment repeated. The treatment areas of the separate procedures may be the same, may be different, or may overlap.
[027] Remodeling of genital tissue, by modalities of the invention, may include thermal denaturation of collagen in areas rich in collagen in target tissues. Since the overlying mucosal epithelium is cooled by the method, it is not heated, and is substantially unaffected by the method. The remodeling of the target tissue in the therapeutic zone can occur substantially during the time when the tissue is being heated. Remodeling can also take place substantially after heating has occurred, for example, days or weeks after. Such remodeling comprises biological healing responses to heating stress, and such responses may include the deposition of new collagen. Whether by denaturing existing collagen or later deposition of new collagen, the remodeling effect on the tissue is usually one of contraction or tightening of the tissue. Thus, modalities of invention comprise tightening of the vagina and introitus. The effect of normal delivery on the vagina and introitus is a laxity of these tissues. Since the method comprises tightening these tissues, the method has a rejuvenating effect in that it remodels the tissue in the direction of the conformation it had before undergoing normal delivery.
[028] For example, an apparatus for reshaping a therapeutic zone in the tissue underlying a mucosal epithelium of female genital tissue is described herein. The apparatus may include: an elongated handle configured to be held with two hands; and a treatment tip configured to be removably attached to the elongated handle. The tip may include: a rod comprising a longitudinal axis: an energy distribution element with a contact surface with the epithelium: and an internal cooling chamber configured to internally cool the energy distribution element, in which the distribution element of energy comprises a thermally conductive surface that is adapted to allow cooling of the epithelium during transmission of RF energy to heat the target tissue.
[029] As previously mentioned, the power distribution element can be configured to be substantially parallel to the longitudinal axis of the rod. The power distribution element can be configured to be about 0.75 cm to about 1.25 cm wide, and / or can be about 1 cm to about 3 cm long. The power distribution element can be substantially flat.
[030] In some variations, the internal cooling chamber comprises a plurality of refrigerant nozzles configured to spray cooling fluid on an internal portion of the power distribution element. For example, the device may have three refrigerant spouts. The power distribution element can have at least one RF electrode (for example, four electrodes). The apparatus may also include at least one temperature sensor located in close proximity to the power distribution element. The temperature sensor can be a thermistor, for example.
[031] The device may also include a return refrigerant path extending proximally to the elongated handle configured to channel the used refrigerant out of a patient.
[032] In some variations, the device includes a flat cable connecting the handle to the integrated controller. The cable can include a refrigerant distribution channel and a refrigerant return channel, at least one RF power line.
[033] The handle may not include a button or switch controlling the application of RF energy. Instead, the application of RF energy can be controlled by a hands-free mechanism (eg, foot switch, voice activation, etc.) or automatically by a controller, or the like. For example, the handle can be configured to automatically stimulate after proper contact with the tissue has been sustained for a predetermined period of time.
[034] Systems for remodeling a therapeutic zone in the tissue underlying a female genital tissue mucosal epithelium are also described here, the system comprising: an elongated handle configured to be held with two hands, where the handle extends in one direction longitudinal; a treatment tip configured to be removably coupled to the elongated handle (the tip comprising: a plurality of energy distribution elements with contact surface with the epithelia, and at least one internal cooling chamber configured to internally cool the elements of energy distribution, wherein the energy distribution element comprises a thermally conductive surface that is adapted to allow cooling of the epithelium during transmission of RF energy to heat the target tissue); and an integrated controller. The integrated controller can include: a housing; an RF generator inside the housing; a cooling subsystem within the housing; and a controller for controlling the operation of the treatment tip and determining when the treatment tip is in contact with a target tissue.
[035] The system can also include a flat cable connecting the handle to the integrated controller, the cable including a refrigerant distribution channel and a refrigerant return channel, at least one RF power line. In some variations, the system includes a foot switch configured to connect to the integrated controller and trigger the application of RF energy by the plurality of elements driven by energy.
[036] The integrated controller can also include a display configured to display control information. The display can be configured to display a map of the plurality of power distribution elements indicating the contact state.
[037] In some variations, the integrated controller is portable. For example, the integrated system may weigh less than fifteen pounds and / or have a footprint that is less than 25 inches (635 mm) by 15 inches (381 mm) by 16 inches (406 mm) (for example, 23 inches (584 mm) deep, 15 inches (381 mm) high and 16 inches (406 mm) wide).
[038] Methods of determining whether a power distribution element from a treatment tip to an RF energy device is also adequately communicating with a tissue to be treated, without determining an electrical impedance of the tissue. For example, the method may include the steps of: determining the time since the power distribution element of the treatment tip was last activated; measure the temperature of one or more locations on the treatment tip; determine whether the energy distribution element is in contact with the tissue without applying RF energy to the tissue, by comparing the temperature of one or more locations on the treatment tip with a threshold function for the time since the treatment tip was activated by last time; and indicate whether the treatment energy distribution element is in contact with the tissue.
[039] In some variations, the step of comparing the temperature of one or more locations on the treatment tip with a threshold function comprises comparing with a threshold function with an elevation temperature threshold of about 30 to about 180 seconds since the power distribution element of the treatment tip was last activated. For example, the treatment level can rise from about 18 degrees Celsius to a temperature just below body temperature within a finite time range (for example, between about 30 seconds and about 180 seconds) as long as the Power distribution of the treatment tip was activated last. In one variation, the treatment level rises from about 18 degrees Celsius to about 27 degrees Celsius within a finite time range since the power distribution element of the treatment tip was last activated.
[040] Methods for remodeling a therapeutic zone in a target tissue underlying a mucosal epithelium of female genital tissue are also described here. Methods may include: cooling a disposable treatment tip from an applicator from an internal lumen in the applicator, wherein the disposable treatment tip includes one or more elements of atraumatic energy distribution; heat the target tissue using the treatment tip; and reshaping the therapeutic zone of the target tissue.
[041] The method may also include confirming contact with tissue and one or more elements of energy distribution based on the temperature of a portion of the treatment tip in or near one of the energy distribution elements, and the time since the treatment tip was last activated. For example, the step of confirming the contact comprises confirming the contact without applying power. Any of the steps of the previously described method can also be included or applied to this method. BRIEF DESCRIPTION OF THE DRAWINGS
[042] Figure 1 is a perspective view of a device to apply radiant energy to the target tissue during cooling of the epithelium in order to remodel the genital tissue, showing a handpiece and a connected treatment tip.
[043] Figure 2 is an exposed perspective view of a treatment tip.
[044] Figure 3 is an exposed side view of a treatment tip modality.
[045] Figure 4 is a cut-out front view of the treatment tip, showing cooling nozzles that are underlying the energy distribution element that makes contact with the epithelium.
[046] Figure 5 shows frontal views of treatment tip modalities with (A) a single monopolar electrode, (B) a single bipolar electrode, and (C) multiple pairs of bipolar electrodes.
[047] Figures 6A and 6B show frontal perspective views of two modalities of a treatment tip, the treatment side facing up, where figure 6A shows an electrode with a flat surface, and figure 6B shows an electrode with a curved surface.
[048] Figure 7 is a schematic view of the female genitalia representing the mucosal epithelial surfaces that overlap the target tissue, as well as an orientation clock to provide a circumferential reference scheme for the vagina wall.
[049] Figure 8 shows a treatment tip contacting a genital epithelial mucosal surface and the underlying target tissue including the lamina propria and the muscle.
[050] Figures 9A and 9B represent a treatment area for a mucosal epithelium comprising multiple contact sites (figure 9A), and a representation of the treatment area as a mapping grid (figure 9B).
[051] Figure 10A shows a coolant spray pattern on an internal surface of a power applicator as shown in figure 4. Figure 10B illustrates a side perspective view of a coolant jet in an internal cooling cavity. of the applicator tip shown in figure 4.
[052] Figure 11 illustrates a variation of an applicator handle region configured to connect to an applicator tip.
[053] Figure 12 is a longitudinal cross section of an applicator tip of a device including the internal cooling chamber or lumen.
[054] Figure 13 shows a cross section of the interface region of a tip and handle.
[055] Figure 14A shows a coolant spray pattern on an internal surface of a power applicator. Figure 14B illustrates a side perspective view of an applicator tip including a jet of coolant being applied to an internal cooling cavity of the applicator tip.
[056] Figures 15A-15F illustrate a variation of a system for treating the vagina and surrounding tissues, including a handle (handpiece) and treatment tip connected to an integrated controller, power supply and coolant.
[057] Figures 16A-16C show several exemplary views and dimensions of a system such as that shown in figures 15A-15F.
[058] Figures 17A-17C illustrate a variation of a handle including a treatment tip, shown in top, side and bottom views, respectively.
[059] Figures 18A-18E show cross sections of the exemplary handle shown in Figures 17A-17C.
[060] Figures 19A-19E illustrate a variation of the internal chassis forming the integrated controller, power generator and refrigerant system to which the handle is attached.
[061] Figures 20A-20C show different examples of control screens for an exemplary system described here.
[062] Figure 21 is a graph showing the relationship of the tip temperature in the air versus the time since the last treatment, which can be used to calculate whether an electrode is in sufficient contact with a tissue to initiate treatment. DETAILED DESCRIPTION OF THE INVENTION Device
[063] Modalities of the present invention include an apparatus and method for remodeling female genital tissue by applying heat to a target tissue underlying the mucosal epithelium of the surface, while cooling the epithelial surface itself. The apparatus and methods can be incorporated into those of the prior art such as those described by Knowlton, including US 2004/0000316, and others cited in the foundations of the invention, all incorporated by this reference, but include new features in the apparatus and methods that are configured and adapted to the particularities of the female genital treatment site, the mucosal epithelium in contact with the present apparatus, and the underlying target tissue that is remodeled according to aspects of the invention. Figure 1 shows an apparatus 1, comprising a handpiece 2 and a treatment tip 10. Handpiece 2 is adapted to be held by an operator, such as a doctor, and may include connections to a support system larger (not shown), or, in some embodiments, can be operable as a self-contained independent device. Figure 1 shows the connector portion 15 of the treatment tip stem, the narrow intermediate section 24, and the distal portion 28, which includes the energy distribution element 30.
[064] Figures 2 - 5 provide several views of the treatment tip. Figure 2 provides an exposed view from a proximal perspective to the tip, Figure 3 is an exposed view from a side perspective, and Figure 4 is a front view facing the power distribution element, exposed in order to reveal the nozzles directly below the power distribution element. Figure 5 shows the treatment tip modalities that vary with respect to the type of energy distribution element (that is, radiofrequency electrodes, varied monopolar, one bipolar pair and multiple bipolar pairs). The treatment tip 10, shown in more detail in figures 2-5, includes a housing 26, a portion of the connector 15, and an energy distribution element 30, which receives wire input 31 (figure 3). The treatment tip as a whole is designed as a quick connect / disconnect unit with respect to its attachment to the lower handpiece 2. The connection of the treatment tip 10 to the handpiece 2 is through the connector portion 15 of the treatment tip. The housing 26 defines an internal space 29 that extends forward from the connector portion 15 to the distal end 28 of the treatment tip. The energy distribution element 30 is mounted on its side with respect to the axis of the linear tip, configured to face outwards on one side in the distal portion 28 of the tip. Mounted on its side, or mounted so as to face one side of the treatment tip means that the energy distribution element 30 is configured to be approximately parallel to the axis of the linear rod 20.
[065] Between the connector portion 15 and the distal portion 28 of the tip is the intermediate portion of the narrowed intermediate section 24, such narrowing or taper on the same side towards which the power distribution element 30 faces (narrowing can generally occur in the middle section 24, but modalities typically include narrowing at least on the same side of the power distribution element). The side-mounted configuration of the energy distribution element 30 and the conical section 24 of the tip are both adapted to optimize the contact of the energy distribution element with the epithelial surfaces of the female genitalia, in particular those of the vagina. Details of the female genitalia are further described below. In order to describe the advantage of lateral placement 22 and the conical section 21 of the nail, the appearance of the canal-like vagina and penetrating it with an instrument that fits the side of the canal are considered. An elongated structure well suited to penetrate the vagina, and to make a substantially flat contact, or surface to surface, parallel to the side of the vagina, a side-mounted power distribution unit is advantageous. An advantage conferred by the parallel contact is that the contact pressure is distributed equally in the contact area, with no pressure predisposed against either side of the contact place. With a uniformly pressurized contact like this occurring, the energy is also uniformly directed to the underlying target tissue. The narrow middle section 24 of the stem additionally provides a functional advantage to the tip 10 in that it allows the energy distribution element 30 in the distal portion 28 of the tip to project towards the front of the stem body, such a projection allowing the physician to operate the device to make contact with the epithelium with appropriate pressure, to make the contact more discreet, to make the contact flat, and to visualize the contact better.
[066] The overall length of the treatment tip 10 in this initial example, from the base of the connector portion 15 to the point further away from the distal portion 28 is designed in such a way that the side-mounted power distribution element 30 reaches the region innermost vagina that is treated by the tip. In this way, tip shapes can have an overall length between about 2.75 inches and 4.25 inches. Even more modalities have an overall length between about 3 inches and about 4 inches. Even more particular arrangements have an overall length between about 3.25 inches and about 3.75 inches. This general length is appropriate to provide the treatment tip with access to the lower portion of a gently unfolded vagina.
[067] The energy distribution element 30 also has dimensions advantageously adapted to make appropriately flat contact with the vaginal wall. The width of the element, an RF electrode in typical modalities, in some modalities, is between about 0.7 cm and about 1.3 cm. In other embodiments, the width is between about 0.8 cm and about 1.2 cm. In still other embodiments, the width is between about 0.9 cm and about 1.1 cm. In some embodiments, the length of the energy distribution element 30 is between about 2 and about 3 cm. In other modalities, the length is between about 2.25 cm and about 2.75 cm. The restrictions regarding length are related to the advantageous aspect of being able to make contact in particular places in the mucosal epithelium, to avoid contact with other places, deeper in the vagina, where it is not desired to make contact, and generally to make discreet and efficient contact in the area. desired treatment. The cutting edge treatment method involves treating the vagina at a point no deeper than about 3.5 cm from the introitus. The restrictions regarding the width of the power distribution element are related, as described above, to the desire to be able to make a substantially flat contact with the internal aspect of a curved surface. By restricting the width of the contact site, greater pressure or contact stiffness that would occur along the longitudinal edges is minimized.
[068] In the modalities shown here, the power distribution element had a flat configuration. Figure 6 shows another embodiment of the treatment tip 10, where the energy distribution element 30 takes on a curvilinear shape. In other embodiments, the energy distribution element comprises a curved surface in such a way that it includes a curvature radially with respect to the linear axis, while still keeping parallel to the linear axis, the shape representing an arc of a cylinder. Figure 6A shows a treatment tip modality where the energy distribution element is flat, while the modality in figure 6B has a curved surface, the curve being radial with respect to the linear axis of the tip. The arc of curvature can be up to approximately 30 degrees. Some modalities may include a curvature of about 30 degrees. The 30 degrees of curvature are adapted to fit the curvature of the vaginal wall.
[069] In this way, several configurational and dimensional aspects of the treatment tip 10 and the energy distribution element 30 are advantageous for the genital tissue remodeling method. These features are particularly suitable for treating the vaginal wall, but are also suitable for treating mucosal epithelial surfaces of the female genitalia outside the vagina. As described here, these features include (1) the side facing the orientation of the power distribution element with respect to the linear axis of the treatment tip and its rod, (2) the overall length of the treatment tip from its proximal end to the distal end, (3) whose narrow portion 24 of the tip allows the energy distribution element to project towards the front of a bottom structure, instead of being in the plane contiguous with the surrounding structure, (4) the surface dimensions of the energy distribution element, particularly the width, which allow substantially flat contact with the vaginal wall in the case of a flat energy distribution element 30, and (5) in the case of the embodiment with an energy distribution element curved, a particularly tight fit between the energy distribution element and the vaginal wall can be obtained. All of these features contribute to a uniformly distributed contact between the energy distribution surface and the mucosal epithelium, and such a uniform adjustment decreases the likelihood of contact predisposed by the edge, which would damage the epithelium, and affirmatively promotes uniform energy distribution in the area of the site where the energy distribution element makes contact with the epithelium and through which energy is radiated into the underlying target tissue. Flow uniformity over a surface area promotes advantageous uniformity, consistency and predictability in the remodeling response. In addition, and equally important, small variation in flow also minimizes damage to both the epithelium and the target tissue, which can occur when large excursions of energy flow include, as inevitably occurs, areas that receive high rates of energy flow .
[070] As seen in figures 2 and 3, the internal space 29 of the tip accommodates a cooling system to cool the energy distribution element, which comprises a cooling lumen 54 to transfer cooling fluid 52 to the nozzles 56. The Cooling fluid can comprise a refrigerant, such as 1,1,1,2-tetrafluoroethane (R 134A), which is stored in a reservoir (not shown) under pressure, and can be transferred through a lumen 54 to nozzles 56 The nozzles are configured in the internal space (internal cooling chamber) 29 in the distal portion 28 or the tip 10 under the internal surface of the energy distribution element 30. Upon release of the refrigerant from the nozzles, it is blasted on the interior surface and cools the element as the refrigerant undergoes a liquid to gas transition. The outer surface of the energy distribution element, when in contact with an epithelial mucosal surface as during the practice of the method of the modalities of the invention, cools the epithelial surface through such contact. This superficial cooling can prevent the accumulation of heat on the mucosal surface, the energy being delivered when the delivery element passes through the mucosal surface and into the underlying tissue targeted by the invention, which is then heated. Figures 10A-10B and 12-14B, described in more detail below, illustrate cooling systems including refrigerant jet and refrigerant removal and / or recycling.
[071] The power distribution element 30 can be any one of an RF electrode, a microwave emitter, or an ultrasound emitter. Modalities that include an RF electrode will be described in some detail. The RF electrode, in some modalities, is a capacitive electrode, which capacitively couples to the mucosal epithelium. The RF electrode, without limiting the scope of the invention, can have a thickness in the range of about 0.01 to about 1.0 mm.
[072] The RF electrode 30 has a conductive portion 35 facing the internal space 29 at the treatment tip, and a dielectric portion 36 facing outside the tip. Conductive portion 35 may comprise a metal, exemplary metals including copper, gold, silver and aluminum.
[073] The dielectric portion 36 can comprise a variety of different materials, including, for example, polyimide, Teflon (RTM) and the like, silicon nitride, polysilanes, polysilazanes, polyimides, Kapton and other polymers, antenna dielectrics and other dielectric materials well known in the art. Other exemplary dielectric materials include polymers such as polyester, silicon, sapphire, diamond, zirconium-hardened alumina (ZTA), alumina and the like.
[074] The dielectric portion 36 covers the conductive portion 35, and is arranged between the conductive portion 35 and the patient's tissue during treatment. In another embodiment, the RF 30 electrode is made of a composite material, including, but not limited to, copper metallized with gold, copper-polyimide, silicon / silicon nitride and the like. In one embodiment, the conductive portion 35 adheres to the dielectric portion 36 which can be a substrate with a thickness, by way of example, and without limitation, of about 0.001 "(0.025 mm). This embodiment is similar to a plate material standard flexible circuit commercially available in the electronics industry In this embodiment, the dielectric portion 36 is in contact with the mucosal epithelium, and the conductive portion 35 is separated from the mucosal epithelium.
[075] In general, RF 30 electrodes can be either monopolar or bipolar. In monopolar mode, RF current passes through the body tissue of a return electrode that can be in the form of a conductive pad applied to another portion of the patient's body. Figure 5 shows various electrode modalities from a confronting perspective, for example, Figure 5A shows a tip with a monopolar pair of electrodes, Figure 5B shows a bipolar pair, and Figure 5C shows a tip with multiple bipolar pairs. In addition, the electrode can be equipped with an integrated EEROM programmable memory chip (Electrically Erasable Read Only Memory, also known as EEPROM) at any suitable location on the treatment tip (not shown). A chip like this can provide identification information or other information regarding the operational status or configuration parameters of the RF electrode to the system, such parameters may include, for example, the type and size of the electrode, the number of times the power distribution element was fired, and the like. In addition, thermistors (thermal sensors) 38 (shown in figure 4) can be provided at each corner of an RF electrode, or otherwise in close proximity to the electrode, to provide feedback to the system regarding the temperature at its location.
[076] In some embodiments, the treatment tip as a whole is designed as a single-use disposable component, while handpiece 2 is typically a reusable instrument. The single use and disposable aspects of the treatment tip 10 are in accordance with its designated use in a single procedure, in the context of a female patient with a procedure, by method modalities further described below, in a medical setting. In this way, the entire construction and components of the treatment tip maintain their integrity through sterilization procedures, and the tip is typically packaged individually in a container or wrap that preserves the sterile integrity of the tip even when it is unwrapped and connected to handpiece 2 in preparation for a treatment procedure. Modalities of the treatment tip 10 are modular in that they have a common connector portion 12, but may have variations in the stem portion 20 and power distribution elements 30 and cooling mechanism components, such as fluid 52 or nozzles 56 . Electronic Device Support System
[077] Device 1 can be included in a larger electronic system with features including a power supply, such as an RF power supply that supplies power to an RF energy generator and energy passes from there to the RF 30 electrodes. A multiplexer can measure, current, voltage and temperature, in the thermal sensors 38 associated with each RF electrode 30. The multiplexer can be driven by a controller, which can be a digital or analog controller, or a computer with software. When the controller is a processor (such as a computer's microprocessor) it can include a CPU coupled via a system bus. In the system, there may also be a keyboard, disk drive, or other non-volatile memory systems, a display and other peripherals. Also connected to the bus can be a program memory and a data memory.
[078] An operator interface includes operator control and a display. The controller can be coupled to different types of imaging systems, including ultrasonic, thermal sensors 38, and impedance displays 39. Current and voltage are used to calculate impedance. A diagnostic phase can be initially run to determine the level of treatment activity. This can be done by ultrasound, as well as by other means. Diagnosis can be made both before and after treatment.
[079] Thermal sensors 38 measure voltage and current delivered to the desired treatment site; the output for these sensors is used by a controller to control the distribution of RF energy, which can also control temperature and power. A power and / or temperature level set by the operator can be determined to provide operational limits that must not be exceeded. The controller can maintain the established level under varying conditions. The amount of RF energy delivered can control the amount of energy. A delivered energy profile can be incorporated into the controller, as well as a pre-set amount of energy to be delivered. Feedback control can be based on the display of impedance, temperature or other indicators, and occurs on both the controller and the RF generator, if it incorporates a controller. For impedance measurement, this can typically be accomplished by supplying a small amount of non-therapeutic RF energy. Voltage and current are then measured to confirm electrical contact.
[080] Circuit systems, software and controller feedback result in full process control, and are used to change power, duty cycle, monopolar or bipolar energy distribution, flow and pressure, and can also determine when the process is completed by time, temperature and / or impedance. These process variables can be controlled and varied according to the tissue temperature, monitored at multiple locations on the outer contact surface 34, as well as monitoring the impedance for the current flow at each RF 39 electrode, indicating changes in the carrying capacity current of the tissue during the process. In addition, a controller can provide multiplexing, monitor circuit continuity and determine which RF 30 electrode is activated.
[081] Thermal sensors 38 can be thermistors, which have a resistance that varies with temperature. An analog amplifier can be a conventional differential amplifier circuit for use with thermistors and transducers. The output of the analog amplifier is sequentially connected by an analog multiplexer to the input of an analog - to - digital converter. The amplifier output is a voltage, which represents the respective detected temperatures. The output voltages of the digitized amplifier are supplied by the analog-to-digital converter to a microprocessor, which calculates the temperature or impedance of the tissue. In some embodiments, the microprocessor can be a 6800 type, however, any suitable microprocessor or general purpose digital or analog computer can be used to calculate impedance or temperature. The microprocessor sequentially receives and stores digital representations of impedance and temperature. Each digital value received by the microprocessor corresponds to different temperatures and impedances.
[082] The calculated temperature and impedance values can be displayed on a display. Alternatively, or in addition to the numerical indication of temperature or impedance, calculated impedance or temperature values can be compared by the microprocessor with the temperature and impedance limits. When the values exceed the predetermined temperature or impedance values, an alert can be given on the display and, in addition, the RF energy distribution on its respective electrode can be decreased or multiplexed to another electrode. A microprocessor control signal can reduce the energy level by the RF generator, or de-energize the energy delivered to any particular electrode. The controller receives and stores digital values that represent sent temperatures and impedances. Calculated surface temperatures and impedances can be sent by the controller to the display. If desired, the calculated surface temperature of the vaginal mucosal tissue layer is compared to a temperature limit and a warning signal can be sent to the display. Similarly, a control signal can be sent to the RF power supply when temperature or impedance values exceed a predetermined level. Methods
[083] Non-surgical methods and devices for remodeling the tissues of the female genitalia are described here by applying heat to a target tissue underlying the mucosal epithelium of the surface, while cooling the epithelium itself. Typically, tissues are those of women who have one or more normal deliveries, and whose tissues have been stretched by delivery. In particular, the target tissues (Figure 8) are the connective tissue layers such as the lamina propria or submocosa 102 and the muscle 104 underlying the mucosal epithelium 100 of genital tissues. Particular features or areas of genital tissue (figure 7) with an epithelial surface include the vulva and vagina 112, and introitus 114, the entrance to the vagina and a demarcation between the internal and external genitalia.
[084] The heating of target tissue, by modalities of this invention, includes raising the temperature of the target tissue to 80 ° C. The temperature is raised to a level that is therapeutic, that is, to a temperature that causes remodeling, as described here. That portion of the target tissue that reaches the therapeutic temperature for a sufficient time is called the therapeutic zone within the target tissue. The therapeutic temperature, in some cases, can only be up to 45 ° C, or high up to 80 ° C. Some variations of therapeutic methods include heating the target tissue to 80 ° C. The target tissue can be heated to a temperature between about 45 ° C and about 80 ° C. In other embodiments, the target tissue can be heated to a temperature between about 50 ° C and about 75 ° C in still other embodiments the target tissue can be heated to a temperature between about 55 ° C and about 70 ° C .
[085] The vagina is a fibromuscular tube, lined with stratified squamous epithelium that connects the external and internal organs of the female reproductive system. The vagina is arranged obliquely up and back at an angle of about 45 degrees between the bladder in front and the rectum and anus behind. In an adult female, the anterior wall is about 7.5 cm long and the posterior wall is about 9 cm long. The difference in length is attributed to the angle of insertion of the cervix through the anterior wall. More particularly with respect to the vagina, embodiments of the invention comprise reshaping the lower portion of the vagina, the lower portion, the lower portion being the portion immediately into the introitus. Thus, according to the modalities of the invention, the portion of the vagina to be treated is a region between the introitus and a position located no more than about 3 to about 4 cm into the introitus. Regarding the circumferential aspects of the vagina, locations along the circumference of the vaginal wall can be associated with a clock position (see reference clock dial 136, in figure 7) in such a way that the circumferential point closest to the urethra is in 12 hours. Using this guidance, embodiments of the invention comprise treatment and remodeling of the vagina in the 300 degree circumferential arch from about 1 hour to about 11 hours.
[086] The mucosal epithelium of the vulvar tissue outside the vagina and introitus includes the labia minora, or that portion of the vulva extending out of the introitus to the Hart line, the limit where the mucosal epithelium and the labial skin meet (figure 7). The mucosal epithelium and the skin, although contiguous, are embryologically and histologically distinct. The portion of the female genitalia that is covered by the epithelium is also substantially defined by the connections of the vestibule, which extends outward or downward from the hymenal ring at the top of the vagina, radially beyond the introitus, including the portion of labia minora located in the line Hart 120. The target tissue of modalities of this invention includes the connective tissue underlying these mucosal epithelial surfaces of the genitalia, which, progressing from the epithelial surface, are known as lamina propria 102 and muscular 104 (figure 8), respectively (see, for example, example, Netter, Atlas of Human Anatomy, 4th edition, Saunders, 2006). The lamina propria includes a mixture of cell types that populate the connective tissue, such as fibroblasts, and the muscle is a layer of smooth muscle. Collagen is secreted or deposited in the extracellular space in these tissues by cells such as fibroblasts. Those layers of target tissue described below the epithelium that overlap deeper tissues, including endopelvic fascia, are not typically targeted, and may not be affected by the systems described herein.
[087] The remodeling of the connective tissue underlying the mucosal epithelial surfaces does not substantially affect the epithelium itself. The method and apparatus, provided by the modalities of the invention, are non-invasive and substantially non-ablative of genital tissue. The nature of the fit between the device and the genital tissue is to contact a treatment tip with an epithelial surface of the genital tissue. Through such contact, the device delivers heat to the underlying tissue, further preventing the surface epithelium from heating up by cooling it.
[088] In a particular embodiment, the invention provides a method and apparatus for remodeling target vulvar and vaginal tissue by using a radiofrequency (RF) energy source 30 (see the power distribution element in figures 1-5) through vaginal or vulvar epithelial mucosal tissue and the respective underlying layers that are the target tissue of modalities of the invention. Other modalities may make use of other forms of energy, such as microwave or ultrasound. The impedance across the mucosal epithelium is less than that of the skin, so less energy is needed to cause heating than it would be where the skin being treated is than the mucosal epithelium.
[089] The application of energy to the underlying connective tissue creates heat in the target tissue, and heat is understood to have an immediate or almost immediate effect of denaturation or partial denaturation of the collagen in the tissue, this collagen denaturation being a factor in remodeling of the fabric. In other embodiments of the invention, it is understood that the application of heat to the connective tissue during a treatment procedure results in a subsequent deposit of new or nascent collagen by the cells of the connective tissue, as part of a biological process that can occur in the course weeks or months after the procedure.
[090] As provided by the modalities of the invention, the remodeling of genital tissue, either by denaturing collagen in the tissue, or by the subsequent deposition of new collagen in the tissue, results in a tightening of the genital tissue, particularly that of the vagina and introitus. A consequence of heating the target tissue may include the fusion or denaturation of pre-existing collagen in the tissue, which can reduce or compact the volume occupied by the collagen, the effect of which is to tighten the surrounding tissue. A long-term biological consequence of heating may include a healing process in which there is an increase in the rate of cell production and deposition in the extracellular space. Both types of responses mean that the almost immediate response to pre-existing collagen and the greater amount of collagen in the long term contribute to a tightening of the target tissue.
[091] The tightening of tissue is such that the remodeled genitalia takes on a rejuvenated shape, a conformation of the genitalia as it was before it was stretched by natural birth. Remodeling of genital tissue, practiced by the modalities of this invention, can be understood in various ways as contraction or tightening of tissue, this can apply to the vulva, vagina and introitus. Genitals rejuvenated by the practice of modalities of the invention, due to the tightening of the vagina and remodeled introitus, for example, allows greater pressure and friction during sexual intercourse and, in this way, can provide greater sexual satisfaction for a woman with such remodeled genitalia and for your sexual partner.
[092] Modalities of the invention provide a method and apparatus for creating a reverse thermal gradient that uses one or more RF 30 electrodes, to transfer energy that manifests as heat in the target tissue, and a mechanism for cooling the epithelial surface above the underlying target layers . A purpose of cooling the epithelial surface is to protect it from the potentially damaging effects of excess heat that would accumulate in the absence of cooling. The epithelial surface is thus a conduit for energy that passes through the underlying layers, but the energy does not manifest in the form of a higher temperature on the epithelial surface. As such, the epithelium itself is not damaged or substantially modified by the method. Such protection against heating can derive both from the heat dissipation aspect of a cold body, as well as from an increase in the impedance of the tissue that is associated with the cooled tissue.
[093] In some embodiments, the device's cooling mechanism includes a lumen 54 adapted to accommodate a cooling fluid transferred to the nozzles 56, which cools the power distribution element 30 of the treatment tip 10 of the device. Modalities of the method thus allow contact from a contact site on a genital epithelial surface, the tip having the capacity both to cool the surface epithelium and to heat the underlying tissue. The cooling fluid cools the treatment tip of the apparatus, provided by modalities of the invention; in turn, the surface of the cooled treatment tip cools the surface of the mucosal epithelium with which the treatment tip makes contact. As provided by embodiments of the invention, the epithelial surface can be cooled to a temperature range from about 0 ° C to about 10 ° C. As energy from the tip passes through the mucosal epithelial surface, the underlying soft tissue can be heated to a temperature range of about 45 ° C to about 80 ° C. Thus, a reverse thermal gradient is created, with a lower temperature in the mucosal epithelium, and a higher temperature in the underlying tissue.
[094] In some embodiments, the method includes feedback control mechanisms to control heating in such a way that the temperature does not exceed a predetermined level. As provided by the device modalities, the feedback is provided to the RF delivery by thermal or impedance sensors. In other embodiments, the method can be controlled by delivering a predetermined total amount of energy. In some embodiments, the method can be controlled by delivering a quantity of energy over a predetermined period of time.
[095] More specifically, within the target tissue of the invention, a treatment zone can be defined, where the heat is particularly focused, or where the heat reaches a level of temperature sufficient to cause remodeling. A treatment zone like this can be centered at a particular depth below the epithelium, and the treatment zone can have a particular range of depth, it can, for example, be distributed roughly across the entire strip of the lamina propria and muscle, or it can occupy a relatively flat area. In some embodiments of the invention, the cooling can continue inside the target tissue itself, below the epithelial surface, to form a zone of tissue protected from cold. The cooling of a portion of the target tissue can have an effect on the therapeutic zone, in such a way that the depth and reach of the therapeutic zone can be modulated or displaced with respect to where such cooling of a portion of the target tissue would be absent. If the cooling penetrates to a certain level in the target tissue to create a zone protected from the cold, for example, the therapeutic zone can be pushed further into the target tissue. In addition, lower temperature in general tends to contain the spread of heat, thus focusing the therapeutic zone on a narrower range of depth.
[096] In typical embodiments of the invention, the method allows surface cooling to coincide with the time that the heat is being delivered to the underlying tissue. In some embodiments, in addition to cooling the surface while heating the underlying tissue, the method includes a cooling period before the application of heat. In other embodiments, the method includes a cooling period after the application of heat. In still other embodiments, the method includes cooling both before and after the application of heat.
[097] As shown in figure 8, a treatment tip 10 of the device makes contact with a contact location 102 in the genital epithelium 100, and such contact creating a location in the epithelium corresponding to the surface area within the contour of the treatment tip profile. . Figure 8 shows the distal end 28 of the tip, with the energy distribution element 30 (shown by dotted lines) facing the mucosal epithelium. Also shown below the contact site 102 (with dotted lines) are layers of target tissue, the lamina 104 and the muscular 106. In typical embodiments of the invention, the method includes making contact with the epithelium, delivering energy, and then moving the treatment tip to another contact place, and deliver energy to it. A procedure, such as that which would occur on a visit to a doctor's office, would typically include a radial sequence of contact of the epithelium inside the vagina and / or contact from other locations outside the vagina. During the same procedure, the treatment tip can be returned to the same point of contact multiple times. The circumference of the lower portion of an unfolded vagina, gently stretched as it is during the practice of this method, is approximately 12 cm. In this way, with a treatment tip about 1 cm wide, a series of about 10 contact points allows to complete a 300 degree circumference arc, between the 1 hour and 11 o'clock positions. These dimensional considerations form the logical basis for a treatment modality in which the surface of the energy distribution element has a curvature of about 30 degrees, each contact place accounting for about 10% of the 300 degree arc.
[098] Figure 9A is a schematic representation of a vagina 122, with the introitus 124 forming the entrance to the vagina. In a typical procedure, the treatment tip would make contact with several places of contact in the lower vagina, just inside the introitus. As shown in figure 9A, an accumulated set of contact sites 102 has been treated by the treatment tip, and collectively comprises a treatment area in the vaginal epithelium. In some embodiments of the method, a single radial row of locations is contacted, as shown in figure 9A. In other embodiments, one or more additional rows could be included in a procedure, further extending into the vagina, as long as the treatment area remains in the lower portion of the vagina. Contact locations for embodiments of the invention may include regions outside the vagina, but within the limits of the Hart line. Outside the vagina, the treatment area will develop with a flatter appearance, in contrast to the internal radial configuration, characteristic of vaginal contact sites. As additionally provided by the method modalities, and shown in figure 9B, the contact locations can be recorded in a grid 115, the complete grid being a mapped representation of the treatment area, which can be referred to during the remodeling assessment at some point time after treatment. As shown, the treatment grid may contain reference points with respect to the circumferential location in the vagina, provided, for example, by the clock dial scheme.
[099] As previously summarized, a given treatment area can be treated during a single procedure during a visit to the office. The method additionally includes repetitions of such procedures, typically on another day, when the effects of the previous procedure can be assessed. From such an assessment, a judgment can be made regarding the retreatment of a particular area previously treated, or to continue treating other areas. Thus, as provided by method modalities, one or more procedures during follow-up visits may vary the same treatment area, treat a completely different treatment area, or treat an overlying treatment area, partially the same previous area, and partially different.
[0100] As previously mentioned, the cooling system typically includes an internal cooling of the applicator tip so that the power distribution element is cooled during (and, in some cases, before and / or after) applying energy to treat and reshape tissue. Any suitable internal cooling system can be used, particularly those including the use of refrigerant such as a cryogenic material. In some variations, the cooling can be electric (for example, through the Peltier effect or similar). Thus, the cooling system of the tip region can include a cooling chamber as previously illustrated in figures 2 and 3. The cooling chamber can include an open region in which one or more nozzles for spraying or applying coolant can be positioned through a thermally conductive inner surface that is thermally continuous with the outer surface of the power distribution element. The refrigerant can be applied to this internal surface to cool the energy distribution element. Refrigerant can be applied in any appropriate pattern to this internal surface. For example, Figure 10A shows a variation of an internal surface 1001 of a power distribution element that is thermally conductive.
[0101] In figure 10A, the overlapping circles 1003 indicate the spray pattern of the refrigerant that is applied to the internal surface 1001 by eight nozzles, as shown in figure 10B. In figure 10B, the nozzles are spaced opposite each other on the inner surface 1001, and emit a cone-shaped spray pattern 1005 across the opposite surface 1009 of the cooling chamber.
[0102] Figure 11 illustrates another variation of a handle that can be used as part of an applicator device, as described. In this variation, handle 1101 is elongated, and includes a handle region 1003. The handle can also include one or more controls 1005 such as a button, slide, dial, or the like. The control can allow the user to apply energy to the power distribution element, apply refrigerant, or both. The handle may also include one or more indicators to indicate the status and / or orientation of the device, including the tip. For example, an indicator can indicate that the tip is attached / not attached. An indicator can indicate that the device is out of refrigerant. An indicator can indicate that the device is ready for activation. An indicator can indicate the tip temperature (for example, the power distribution element), and / or the time the device has been active. Any appropriate indicator can be used. In some variations, the indicator includes one or more lamps (for example, LEDs, etc.), colors (including colored lamps), alphanumeric (for example, a display screen or display), or the like. The handle is typically configured to match the tip, as previously mentioned. In some variations, the tip engages the handle quickly or easily attached and detached. Thus, the tip and / or handle can be configured for quick release and quick attachment.
[0103] For example, figure 13 illustrates a variation of the attachment region between a tip 1301 and a handle 1303. The attachment region is adapted to facilitate quick attachment / detachment. The tip and handle are both configured to connect the electrical connector (activating the power distribution element), and a refrigerant delivery line, as well as a refrigerant return line. The refrigerant delivery line is a channel through the handle and tip through which refrigerant can be delivered for release into the cooling chamber, as previously described. The refrigerant can be pressurized, so the connector has to be adapted to handle high pressures without leakage. Thus, the device can include redundant seals at the tip and handle interface, as shown in figure 13. For example, the high pressure seal can be configured as two or more (for example, three) high pressure face seals. In this variation, the seals are not annular seals, which can reduce the pulling force required to separate the tip and handle. In some variations, the refrigerant return line (or refrigerant return channel or path) is a low pressure return line through which the refrigerant can be channeled. The refrigerant return line can be configured to remove refrigerant from the device (including the tip and handle region) in a way that is not ventilated or released. In some variations, the refrigerant return line ventilates or releases the refrigerant, but releases it from a location that is remote from the patient and / or the technician who operates the device. For example, the handle may include a refrigerant return channel that ventilates the refrigerant proximally, along a wire or connector on the handle, out of the patient.
[0104] Attachment handle 1301 can be easily attached and / or detached from tip 1303. For example, attachment regions 1313 can be configured to seal with a plurality of easy-to-release contact points, instead of a single seal or contact point that would require more force to separate (such as annular seals). The seals can instead be configured to require only a small release force. By increasing the number of contacts / seals and / or the surface area of the seals, a lower release / connection force can be used to form a sufficiently stable connection. For example, the area of the sealing surface can be increased, which provides sufficient sealing.
[0105] In some variations, the refrigerant is collected and / or recycled. For example, the refrigerant return path can connect to a refrigerant return reservoir that collects used refrigerant. This refrigerant can be recycled or reused later. In some variations, the system includes a compressor or recycler to reuse the refrigerant.
[0106] Figure 12 shows a cross section through another variation of a tip of a device 1201 including a cooling chamber 1203 with a plurality of (three) nozzles to apply refrigerant through the cooling chamber 1203 and on an interior surface of the power distribution component 1205. In this variation, the sprinkler has been optimized so that the relatively large area of the inner surface of the power distribution component 1205 is cooled smaller cooling nozzles 1207. For example, in figure 12, the device includes three nozzles 1027 that are responsible for cooling most (virtually all) of the interior surface of the power distribution component, as illustrated in figure 14A.
[0107] Figures 14A and 14B show, respectively, the spray pattern of a device with only three nozzles for delivering refrigerant inside the housing. In this variation, the nozzles are angled to target longitudinally separated (although overlapping) regions of the interior surface of the energy distribution component, thereby cooling it. The arrangement illustrated in figures 14A and 14B is considered more efficient than the configuration shown in figures 10A and 10B, in which eight nozzles are used to apply refrigerant in the same space. Although there is less overlap in the refrigerant, it is believed that the energy distribution component can be cooled efficiently, virtually at the same time, as with a larger number of nozzles. Nozzles 1207 shown in figures 14B and 12 (which illustrate the same variation) apply refrigerant to most of the thermally conductive internal surface of the energy distribution component. Since the inner surface is thermally conductive, cooling the inner surface (even a portion of the inner surface) will result in cooling the outer surface of the energy distribution component of the tip, and thereby cooling the tissue in contact with this tip. System
[0108] A vaginal remodeling system may include a handle, a disposable (or reusable) treatment tip, an energy source / power supply, a plurality of temperature sensors, a cooling subsystem and a controller. In some variations, the controller, power supply / power supply and cooling subsystem can be integrated into a single unit to which the handle and tip can be coupled. This total system can be configured for ease of use, including portability and compact layout.
[0109] For example, in a variation, the system can include: a treatment tip (for RF energy distribution), a coolant source (for example, cryogenic material), a handpiece (handle), a handle connecting the handle and tip on the refrigerant source and / or power supply and / or control system, a power source (eg, RF generator), and a controller. Optionally, the system can also include a coupling fluid, a return pad, a separate control switch (for example, foot switch).
[0110] As mentioned, in some variations, the controller, power supply (RF generator) and cooling system can all be integrated into a single unit that is connected (via one or more cables) to the handpiece and treatment tip . For example, figures 15A-15F illustrate a variation of a system including the integrated controller with power supply and coolant that connects to the handpiece and tip.
[0111] Figure 15A shows a front view of the integrated system, in which the handle is connected via a single handle on a chassis containing the controller, cooling system and RF power supply. For convenience, the integrated controller, cooling system and RF power supply will be referred to as an integrated controller, which includes both the integrated cooling system and power supply that can be controlled or regulated by the controller. The system 1500 in this example includes a display 1501 and a housing 1503 to which the handpiece (cable 1505) and treatment tip 1507 are attached via a handle 1509. The cable can include refrigerant supply and return lines, as well as a connection to the RF power supply and any sensor (s) on the treatment tip.
[0112] Figure 15B illustrates the back of the device, including an opening into which a refrigerant can be inserted. In this example, the refrigerant is a 1521 refrigerant can that can be attached to the opening and secured in place to provide refrigerant to the system. Figures 15C-15F show rear and side views of the system with the housing removed, exposing the chassis that supports the controller (microprocessor), cooling system and RF power supply.
[0113] In this example, the integrated refrigerant includes a 1521 can that can be attached to the opening in the housing. For example, the refrigerant can be a pressurized can of cryogenic material such as R-134A or another suitable refrigerant. In this example, the refrigerant can can be threaded with one or more sets of threads to hold it in place in the integrated controller, although any appropriate sealing mechanism for the refrigerant can be used. The refrigerant level can be monitored by the controller, and the display can include an icon indicating the remaining refrigerant level in the can or system (see, for example, figures 20A-20C, described in more detail below).
[0114] An example of the integrated system chassis is shown in figures 19A-19E. The chassis supports the components of the integrated controller, such as a microprocessor (which may include hardware, software and / or firmware) to control the system), any output (for example, display, one or more speakers, etc.) RF power supply, and the cooling subsystem. These different portions of the integrated controller can be partitioned within the housing, in the support chassis, in a way that allows them to be "modular". For example, all or parts of the integrated controller can be modular to allow them to be easily replaced with new or remanufactured components. For example, figure 19A shows a side view of a chassis with all components removed. Removing the side panels from the housing can expose the internal regions or compartments in which the various components are positioned. Figure 19B shows a perspective view of a top part of the chassis, which can also be removable, while figures 19C and 19D show perspective views of the front and inner regions of the chassis. Figure 19E shows a perspective view of the rear and base parts of the chassis.
[0115] The chassis can include rails or supports that allow multiple regions or components to be inserted and removed (pulled out) easily. The general arrangement of components in the housing may include panels and vertical and horizontal regions, which can be easily accessible.
[0116] In the example, the system shown in figures 15A-15F, the handle and tip are shown attached on the side of the device, near the front. In some variations, the handle is attached to the integrated controller by a central front region. This can allow the maximum reach of the handle, regardless of the orientation (or orientation of use of the hand) of the device user. The integrated controller can also include a support or cradle for the handpiece. In some variations, the controller housing may include a cradle housing embedded in the housing, or extending from either (or both) sides of the housing.
[0117] The overall weight and footprint of the system, and particularly the integrated controller, can be small enough so that the device is portable and easily storable, which can be important for moving between surgical or clinical environments. For example, figures 16A-16C illustrate an exemplary set of dimensions for a system including an integrated controller (integrating the controller, RF generator and cooling system). In this example, the integrated controller is less than approximately 23 inches (584 mm) long (deep), 15 inches (381 mm) high and 16 inches (406 mm) wide. The entire system can weigh less than 50 pounds.
[0118] The system can also include one or more controls to control the device. In particular, the system may include a control to deliver energy from the treatment tip (eg, activation control), as well as one or more controls to control the treatment regime, for example, communicating with the integrated controller.
[0119] In the example shown in figure 15A, the display screen shown is a touch screen that allows the user to select treatment parameters by touching the screen. As previously mentioned, in some variations, the system may include a keyboard, mouse, mouse, or similar.
[0120] In some variations, the activation control is included in the handpiece (for example, handle), including a button, as shown in the handles for holding above-discussed specimens. However, it may be unexpectedly advantageous to include a treatment handle that does not include a button such as an activation control. As previously described, since the user may be applying energy to the device to treat in a variety or orientations related to the patient (typically tilted), it may be more convenient to include a foot switch to control activation. Thus, in some variations, the system may include a wired or wireless foot switch, or another control that is separate from the handpiece. In one variation, the foot switch is connected to the integrated controls (for example, by a wire or wire extending from the housing).
[0121] As mentioned, the handpiece (handle) is typically connected to the integrated controller by a cable or wire (including a delivery / return for refrigerant, energy, etc.). The wire length of the handpiece can be optimized for flexibility, support strength and length. The cable must have sufficient support to allow delivery and return of the refrigerant (in addition to the power lines for RF energy and / or any sensor) without entanglement, which may otherwise block or prevent delivery of the refrigerant at the treatment tip. However, cables with sufficient strength for use with the refrigerant can be too thick or rigid, making handling difficult. It has been determined that a flat cable (as illustrated here) in which the various channels are arranged in parallel can allow for sufficient flexibility to allow easy control without sacrificing resistance. In contrast, a round cable can be more rigid and more difficult to control.
[0122] Similarly, in some variations, the system may include a rotating connector for the cable, both in the handpiece and in the controller housing, as well as both. A rotating connector can allow the handpiece to be rotated in relation to the wire / cable (for example, in relation to the wire length). This can make it easier to use the handpiece during treatment, where it can be rotated to treat different regions of the patient. In addition, the system may include modifications to increase user comfort during the treatment of the patient, particularly given the required weight of the handle and cable. For example, in some variations, the system includes a support for lifting the cable above the work area, so that the user does not have to support the total weight of the wire / cable. In some variations, the wire / cable is approximately six feet long, or less.
[0123] As described in more detail below, the handpiece or handle can also be adapted to increase comfort and facilitate use, in addition to removing the switch, as previously mentioned. Holding cable
[0124] Figures 17A-17C illustrate a variation of a handpiece (handle) for a vaginal remodeling device. This variation includes adaptations that improve the control of the handpiece during treatment of a typical patient. A difficulty in treating patients using any of the remodeling devices described herein or known in the art is the fatigue observed by the operator when handling the handle. The typical handle can be awkward to use, particularly since the handle may need to be secured against the patient's tissue long enough to maintain the electrical connection with the tissue for effective delivery of RF energy. In addition, the device must be secured in proper orientation towards the patient. The surfaces of the vagina are angled in relation to the vaginal opening, requiring the user to rotate the handle in relation to the patient from various angles in order to achieve complete coverage of the treatment area.
[0125] In figures 17A-17C, handpiece 1701 (shown with attached tip 1703) is an elongated handle configured so that it can be easily held by two hands, although it can be light enough to be held by one hand. hand. For example, the handle may be slightly straight (elongated) extending proximally from the distal treatment tip along the same axis as the treatment tip. The handle can include two handle regions, which can include two or more shallow "strangulation" regions forming the handle regions 1705, 1707. As previously described, the treatment tip can be connected and include sealing regions to seal the lines of refrigerant delivery and return. The handle can be without actuation buttons (although in some variations it may include an activation button) and can be used with a foot switch or other activation switch.
[0126] In some variations, both the handpiece and the treatment tip, and both, include 1721 markings that can indicate the depth inside the vagina. This can allow the user to maintain a desired depth of use.
[0127] Figures 18A-18D illustrate several cross sections of the exemplary handle shown in figures 17A-17C.
[0128] In the example shown in figures 17A-18D, the handpiece and tip are approximately 13 inches long. The dimensions shown in figures 18A-18D are exemplary only; these dimensions (shown in inches) can be modified without evading the invention. In general, the handle is long enough to be easily held by two hands. The handle can be relatively rigid (compared to the flexible, typically flat cable, for example). In some variations, the handle is between about 8 inches and about 16 inches long (for example, more than 8 inches long, more than 9 inches long, more than 10 inches long, more than 11 inches long , more than 12 inches long, more than 13 inches long, more than 14 inches long, etc.). In some variations, the handle (including the treatment tip) is preferably more than about 12 inches long (for example, 13 inches long) because it can be used by two hands. The handle can be rigid and light (for example, the inner region can be relatively hollow, as shown in figure 18D). Thus, the handle can be manipulated with a single hand, although long enough for use by two hands. Control system
[0129] The controller, including the integrated controllers described above, can include a display that is configured to display information regarding the procedure, refrigerant, treatment tip, handle and other system components. This information can be displayed in front of the integrated controller, and can also display the information with audio signals. The display can also be used to display error information (including error codes) based on the status of the various components in the system (eg, refrigerant level, skin contact, RF generator status, etc.).
[0130] In a particular example, the system includes a display indicating the state of the treatment tip. The treatment tip can include a plurality of RF electrodes. For example, the tip may include an arrangement of four electrodes arranged adjacent to each other. The tip may also include a plurality of sensors to indicate whether each electrode is in proper contact with the tissue to be treated. Figures 20A-20C illustrate three exemplary "screens" of the exhibitor.
[0131] In figure 20A, the screen was divided into five regions showing the status information and instructions to the user. For example, the upper right portion of the screen indicates the 2001 refrigerant level on a scale (sliding) icon. Below this is a graphical representation of the electrodes at the treatment tip 2003. In this example, there are four quadrants (1-4). These labeled quadrants may include a visual indicator that indicates whether the electrode is sufficiently contacting the patient for effective treatment. As previously mentioned, in some variations, this indicator may reflect impedance and / or thermal measurement. In some variations, it is desirable to use a non-electrical determination (for example, no resistance or electrical impedance) of contact with the patient; and an example of a method and system for achieving this is described below. In figure 20A, the contact map 2003 indicates that each of the four quadrants is in sufficient contact. In this case, the lower 2005 region of the display informs the user that the treatment can be started by pushing the foot switch. Figures 20B and 20C are similar to figure 20A, except that the contact maps indicate that the electrodes of the treatment tip are not in sufficient contact with the patient. In figure 20B, it was determined that none of the electrodes are in sufficient contact and, therefore, the system instructs the user to "make contact with the patient" before treatment can continue. In figure 20C, the contact map indicates that half (2 of 4) of the electrodes are in sufficient contact with the patient, and the information icon instructs the user to "make better contact". Figures 20A-20C all indicate the level of treatment to be applied (90 Joules / cm2, in this example), as well as the other tip pulses to be applied (100, in this example). A slide below the indicator for the other peak pulses visually indicates the number of pulses to be delivered for treatment. In some variations, these parameters (the treatment level and the pulses applied to treat) can be selected or modified by pressing the 2009 "adjustment" button and changing or feeding the values.
[0132] In operation, the user can use a touchscreen to start using the device, including selecting stimulation parameters such as the level of treatment and pulses to be delivered. The following is a description of a proposed method of using the devices described here. A. Configuration: Adjusting the treatment tip
[0133] Before treatment, in some variations, the system can be "adjusted".
[0134] The system typically includes a handle and treatment tip that is configured to seal and removably connect to the handle, an integrated controller, RF generator and cooling subsystem, a cable or wire connecting the handle and tip to the controller, and an activation foot switch to connect to the controller. The system may also include a return pad (electrical return), a can of cryogenic material (coolant) and a coupling fluid. The coupling fluid can be provided to help make sufficient electrical contact between the tip and the patient's tissue.
[0135] In some variations, the system can be self-adjusting. In some variations, the system may allow the user to adjust the applicator. To adjust the system, the tip, handle and controller can be matched. By installing a treatment tip on the generator handpiece, the generator user interface screen can be configured to require an adjustment cycle in order to establish the desired RF energy level. The following steps must be performed to complete the adjustment cycle.
[0136] First, confirm that the generator system cables are properly connected and that the patient return electrode pad is complete and properly placed on the patient.
[0137] Then, after installing the treatment tip on the handpiece, wait for the unit generator user interface screen to be ready for adjustment. Press the confirmation button on the front panel of the generator and then press the start / stop button. The generator start / stop button should now be flashing. If it is not flashing, press to confirm the start / stop button again. If the start / stop button does not start flashing, uninstall and reinstall the treatment tip on the handpiece and repeat, pressing the confirmation button and the start / stop button.
[0138] Next, apply coupling fluid to the electrode surface of the treatment tip and then place the electrode on the target tissue within the vaginal introitus. Make sure that the entire electrode surface is evenly seated on the vaginal tissue. The blue lamp on the handpiece will illuminate when the appropriate fabric temperature is reached.
[0139] With the blue lamp on the handpiece illuminated and still maintaining contact of the fabric with the electrode surface, press the RF activation button located on the handpiece or foot switch and keep it pressed until the user interface screen generator display complete adjustment. Occasionally, the generator may require more than one adjustment cycle to complete the adjustment process. If this is the case, repeat placing the electrode on the target tissue and pressing and holding the RF activation button until the adjustment is complete.
[0140] In some variations, the system does not need to be adjusted, but it can be pre-adjusted or matched.
[0141] In some variations, the system may allow the RF energy level to be set at a desired level, before starting the procedure. For example, using a control (for example, a button on the front panel, a graphical interface control using the touchscreen, etc.), the RF energy level can be changed, for example, to 18.0 (180 J) and then confirm and the start / stop buttons or other controls can be pressed.
[0142] In some variations of the system, the energy level of the controller is not adjustable, but is fixed at a particular energy level or range of energy levels that have been found to be effective. For example, in some system variations, the power level of the controller is fixed at approximately 90J. In other variations, the energy level is restricted to a range of about 80J to about 130J (for example, 90J to 120J). Procedural Configuration
[0143] In some variations, the treatment area can be defined as the mucosal surface of the vaginal introitus starting at the hymenal ring, for example, the region covering the area from 1:00 to 11:00 and avoiding the areas immediately below and adjacent to the urethra. To set up for treatment, the user can first clean and prepare the treatment area and the surface around the vagina with a non-alcohol based cleanser. The user can then confirm that the integrated controls (RF generator, cooling and control module), handpiece and foot switch (if used), are properly configured, and properly connected.
[0144] Then, the electrode of the patient's return pad can be placed in contact with a clean dry area of the skin on the patient's underside or lateral area (above the hip) and the treatment tip can be completely pressed over the handpiece before use. Ideally, the treatment tip should be in full contact with mucosal tissue for safe operation. To treat, the treatment area and treatment tip can be bathed with coupling fluid to ensure good electrical contact with the treatment surface. Additional coupling fluid can be applied during the treatment procedure.
[0145] The user can use the device with a retractor, if desired, although care must be taken not to contact the applicator (electrodes) of the treatment tip with any retractor. In some variations, the energy setting is 180 J. The energy density is 90 J / cm. Still ensuring that the treatment tip is in good contact with the treatment surface and confirming that the blue lamp on the handpiece is illuminated, RF energy can be applied to the target area by activating the switch on the handpiece or foot switch.
[0146] In some variations (for example, using the treatment tips and devices described here), each application of energy can treat an area of 1 cm x 2 cm. Starting in a clockwise direction, the treatment tip can be applied to the vaginal mucosal surface of the vaginal opening beginning at the hymenal ring, covering the entire area from 1:00 to 11:00 hours, avoiding the urethra. To ensure complete coverage, the application of energy can overlap by 50% or 0.5 cm2. This step can be repeated until a total of five (5) passes are made in the treatment area. Contact Confirmation and System Control
[0147] As previously mentioned, the system can be configured to confirm that the applicator tip and particularly the energy applicators (for example, electrodes) are in good contact with the tissue to ensure that the tissue will be treated properly, and prevent injury . In some variations, the system includes a display that includes a "contact map" that shows (by color, symbol, text, etc.) that the appropriate contact is being made with the tip and / or the energy applicators. For example, the contact map can display a map of the energy applicators indicating sufficient patient contact for each region of the energy applicator. In figures 20A-20C, for example, the system shows a four-quadrant map of the applicator tip and indicates whether the energy applicator is in sufficient contact with the patient.
[0148] In some variations, adequate contact means adequate electrical contact, and can be determined by applying a low level of electrical current through the electrodes to determine whether the contact is sufficient (for example, by measuring the resistance / conductance between the electrodes and the tissue) . This surprisingly led to problems, however, as the EMC test (electrical interference) of devices including an RF generator demonstrated unacceptable amounts of interference generated at the power line connections. This problem can lead to failure of the system (for example, the generator) in compliance with the EMC limits.
[0149] The reason for this problem may be inherent in the use of the electrical contact test. For example, RF generator tissue contact algorithms typically use electrical impedance measurements to detect whether the tip is completely in the air or in partial contact with the tissue before the delivery of therapeutic RF energy. Impedance measurements require that the RF output circuit system be energized at a low level. This low level produces electrical interference in the connections of the power line. Although RF generators are normally exempt from compliance with the EMC limits during therapeutic energy distribution, this exemption cannot apply to pre-application (for example, contact testing).
[0150] A system and method of determining tip-to-tissue contact that does not require energizing the RF output circuit system prior to delivery of therapeutic energy is described here.
[0151] In some variations of the systems described here, the treatment tips include a plurality of temperature sensing elements (for example, thermistors). For example, the system can include six thermistors, surrounding (for example, at the edges) the four electrodes. In one variation, the system can use a combination of the temperature information for all subsets of the thermistors and the history and time of use of the device to determine whether there is sufficient contact with the patient to operate the system.
[0152] In a variation, which can be used with an impedance / resistance measurement, if the system determines that an electrode has a high impedance that is typically the impedance in air, the system will indicate that the electrode is not in contact with the fabric. If the impedance is low (in a range that can indicate contact with the fabric), the system can indicate contact. However, because the contact may be incomplete or below enough, in some variations, the temperature can be used as a support to confirm that the electrode is in contact with the tissue. For example, when the impedance of an electrode is low, the temperature in the electrode (for example, in a corner of the electrode) can be compared with a temperature threshold to confirm contact. This temperature range is typically a constant (for example, 16 degrees Celsius). For example, if the actual temperature is approximately equal to or greater than about 16 degrees Celsius, then, when the impedance is low, the system can indicate that the electrode is in sufficient contact.
[0153] This "constant temperature" threshold may introduce errors, however, particularly since the electrode's ambient temperature may be more than 16 degrees; even after the electrode operation, when the electrodes are cooled by the application of refrigerant, the tip will heat up above this constant level.
[0154] As an alternative, the system can be configured so that the impedance measurement is unnecessary, using only the temperature measurement and the time since the last treatment (refrigerant) was applied.
[0155] For example, the system can track (for example, using a timing element) the time since the last treatment, and apply a threshold based on the tip temperature (for example, electrode) and the time since the last treatment . If a treatment does not take place for ~ 30 seconds, the tip is likely to be approaching room temperature and should therefore use a uniformly rising temperature level. After ~ 3 minutes, the tip will be close to room temperature and the system can apply a higher fixed level that is above the room (but below body temperature). If the time elapsed from the last treatment is less than a minimum time (~ 30 seconds), the tip temperature may still be below the environment and the temperature threshold may be set at a low value to minimize the waiting time for the cycle next treatment.
[0156] For example, in a variation, the system does not use impedance measurements to confirm the contact, but is based only on the temperature and time since the last activation of the device (application of refrigerant). The temperature of an electrode can be compared with a temperature threshold that depends on the time since the last activation of the device; this relationship can be a non-constant. In particular, the relationship can describe temporal "regions" with different temperatures. In some variations, the threshold relationship is a staggered function, an arcotangent function, or another relationship. The threshold relationship can be referred to as a threshold function (which is a function of time) providing a temperature threshold. The threshold function is typically non-constant (for all time), although it may have temporal regions in which it is a constant. An exemplary threshold function is illustrated in figure 21 ("proposed threshold") and compared with the temperature of a tip in air and a constant threshold. Table 1 illustrates the application of a threshold function to determine whether the

[0157] The example in Table 1 considers that if a treatment did not occur for ~ 30 seconds, then the tip is approaching room temperature and therefore a uniformly rising temperature threshold should be applied to determine if the electrode is making sufficient contact. with the patient (whose tissue will be at body temperature). After ~ 3 minutes, the tip will be close to room temperature and the system will use a higher fixed threshold that is above room temperature (but below body temperature). If the time elapsed from the last treatment is less than a minimum time (-30 seconds), the temperature of the tip is still below the environment and the temperature threshold will remain low to minimize the waiting time for the next treatment cycle.
[0158] In a table, the column entitled "tissue contact determination" gives an example of the synthesis of multiple electrode / tip contact measurements that can be used to determine if the general tip contact is sufficient to continue with the application of energy in the procedure. In this example, if more than half (for example, 3 of 4) of the contact determinations (of four thermistors near the corners of each of the four electrodes) are above the temperature threshold from the threshold function, then the controller can allow (or simply advise, in some variations) to continue treatment in the current position; otherwise, treatment cannot be allowed or advised. In some variations, the number of "good" contacts based on applying the threshold function to a plurality of thermistors can be more than some other percentage (for example, 60%, 75%, 80%, 90%, etc.) or all thermistors must be above the threshold function temperature. In some variations, the location of the thermistor can be weighted to determine whether it allows or advises the user to continue treatment. For example, thermistors that form a continuous horizontal (or vertical vertical) line in the tissue (representing immediately adjacent electrodes) can be weighted more sharply in determining sufficient contact to continue treatment.
[0159] Figure 21 illustrates a variation of a proposal based on a threshold function (similar to that shown in table 1, above) compared to the temperature of a tip and a constant threshold. Even without an impedance measurement that detects a tip in the air, the steadily rising temperature threshold shown by the threshold function proposed in figure 21 can prevent a tip totally or partially in the air from indicating a ready to treat state; raising the threshold between 30 and 180 seconds since the last RF delivery can track the continuous rise in peak temperature in the air. The postponed landing curve (landing function) can be adjusted to optimize the rejection of false contact detection, while minimizing the waiting time for detecting the real contact.
[0160] Other variations of the system, cutting-edge design and associated methods of use can be employed to achieve the objectives of the invention without departing from its scope, as versed in the technique can perceive. The shape and dimensions of the device, including the handle and tip, can also be adjusted to improve the efficiency of the treatment, taking into account physiological and anatomical information. Although various embodiments of the present invention have been shown and described here, such embodiments are provided by way of example only. Any theory of operation or benefit offered in them should only be an aid in describing the invention; such theories and interpretation do not restrict or limit claims with respect to tissue remodeling carried out by the practice of the invention. Numerous variations, changes and substitutions can occur to those skilled in the art without evading the invention. It is to be understood that several alternatives of the modalities of the invention described herein can be employed in the practice of the invention. The scope of the invention, methods and structures within the scope of the invention are intended to include equivalents.

权利要求:
Claims (34)
[0001]
1. Apparatus to remodel a therapeutic zone in the tissue underlying a mucosal epithelium of female genital tissue, characterized by the fact that the apparatus comprises: an elongated handle configured to be safe; and a treatment tip, the tip comprising: a rod comprising a longitudinal axis: an energy distribution element having a contact surface with the epithelium: and an internal cooling chamber configured to internally cool the energy distribution element, in that the energy distribution element comprises a thermally conductive surface that is adapted to allow the epithelium to cool; a controller configured to determine contact with a target tissue and generate a contact map; where the controller is configured to determine a time since the treatment tip power distribution element was last activated, measure the temperature of one or more locations on the treatment tip and determine if the power distribution element is in contact with the tissue without applying RF energy to the tissue, comparing the temperature of one or more locations at the treatment tip with a threshold function over the time since the last treatment tip was activated and whether the element was activated energy distribution of the treatment is in contact with the tissue; and a player configured to display the contact map.
[0002]
2. Apparatus according to claim 1, characterized by the fact that the energy distribution element is configured to be parallel to the longitudinal axis of the rod.
[0003]
3. Apparatus according to claim 1, characterized by the fact that the energy distribution element is configured to have a width of 0.75 cm to 1.25 cm.
[0004]
4. Apparatus according to claim 1, characterized by the fact that the power distribution element is configured to have a length of 1 cm to 3 cm.
[0005]
5. Apparatus according to claim 1, characterized by the fact that the power distribution element is configured to be flat.
[0006]
Apparatus according to claim 1, characterized by the fact that the internal cooling chamber comprises a plurality of refrigerant nozzles configured to spray cooling fluid on an internal portion of the energy distribution element.
[0007]
7. Apparatus according to claim 6, characterized by the fact that it comprises three refrigerant nozzles.
[0008]
8. Apparatus according to claim 1, characterized by the fact that the energy distribution element comprises at least one RF electrode.
[0009]
9. Apparatus according to claim 1, characterized by the fact that it additionally comprises at least one temperature sensor located at each angle of the energy distribution element.
[0010]
10. Apparatus according to claim 1, characterized in that it additionally comprises a return refrigerant path extending proximally to the elongated handle configured to channel the used refrigerant out of a patient.
[0011]
11. Apparatus according to claim 1, characterized in that it additionally comprises a cable connecting the handle on the integrated controller, the cable including a refrigerant distribution channel and a refrigerant return channel, at least one power line RF.
[0012]
12. Apparatus, according to claim 1, characterized by the fact that the handle does not include a button or switch controlling the application of RF energy.
[0013]
13. System for remodeling a therapeutic zone in the tissue underlying a mucosal epithelium of female genital tissue, characterized by the fact that the system comprises: an elongated handle configured to be safe, in which the handle extends in a longitudinal direction; a treatment tip, the tip comprising: an energy distribution element with an epithelial contact surface, and at least one internal cooling chamber configured to internally cool the energy distribution element; wherein the energy distribution element comprises a thermally conductive surface that is adapted to allow cooling of the epithelium; and an integrated controller including: a housing; an RF generator inside the housing; a cooling subsystem within the housing; and a controller to control operation of the treatment tip and determine when the treatment tip is in contact with a target tissue and generate a contact map; where the controller is configured to determine a time since the treatment tip power distribution element was last activated, measure the temperature of one or more locations on the treatment tip and determine if the power distribution element is in contact with the tissue without applying RF energy to the tissue, comparing the temperature of one or more locations at the treatment tip with a limit function over the time since the last treatment point was activated and indicating whether the element energy distribution is in contact with the fabric; and a player configured to appear on the contact map.
[0014]
14. System according to claim 13, characterized in that it additionally comprises a cable connecting the handle on the integrated controller, the cable including a refrigerant distribution channel and a refrigerant return channel, at least one power line RF.
[0015]
15. System according to claim 13, characterized by the fact that it additionally comprises a foot switch configured to connect to the integrated controller and trigger the application of RF energy by the energy distribution element.
[0016]
16. System, according to claim 13, characterized by the fact that the display is configured to display control information.
[0017]
17. System, according to claim 13, characterized by the fact that the integrated controller is portable.
[0018]
18. System according to claim 13, characterized by the fact that the integrated system weighs less than 6.8 kilograms (fifteen pounds).
[0019]
19. Apparatus, according to claim 1, characterized by the fact that the contact surface with epithelium has a plurality of regions that apply energy.
[0020]
20. Apparatus, according to claim 19, characterized by the fact that the contact map comprises a graphic map representing relative positions of the plurality of energy application regions in the energy distribution element, the graphic map showing the status of the contact of each of the energy application regions.
[0021]
21. Apparatus according to claim 1, characterized by the fact that it further comprises a plurality of temperature sensing elements around the energy distribution element.
[0022]
22. Apparatus according to claim 21, characterized by the fact that the plurality of temperature sensing elements monitors the temperature of the tissue in various places on the surface of contact with the epithelium.
[0023]
23. Apparatus according to claim 21, characterized by the fact that the contact map represents a contact status of each of the various temperature sensing elements with the epithelium.
[0024]
24. Apparatus according to claim 1, characterized by the fact that the thermally conductive surface is adapted to allow cooling of the epithelium before transmitting RF energy to heat the target tissue, after transmitting RF energy to heat the target tissue, while transmits RF energy to heat the target tissue, or combinations thereof.
[0025]
25. Apparatus according to claim 1, characterized by the fact that the energy delivery element is curved.
[0026]
26. Apparatus according to claim 1, characterized by the fact that the cable is a flat cable.
[0027]
27. System according to claim 13, characterized by the fact that the contact surface with epithelium has a plurality of regions that apply energy.
[0028]
28. System according to claim 27, characterized by the fact that the contact map comprises a graphic map representing relative positions of the plurality of energy-applying regions in the energy distribution element, the graphic map showing the status of the contact of each of the energy application regions.
[0029]
29. System according to claim 13, characterized by the fact that it further comprises a plurality of temperature sensing elements around the energy distribution element.
[0030]
30. System according to claim 29, characterized by the fact that the plurality of temperature sensing elements monitors the temperature of the tissue in various places on the surface of contact with the epithelium.
[0031]
31. System according to claim 29, characterized by the fact that the contact map represents a contact status of each of the various temperature sensing elements with the epithelium.
[0032]
32. System according to claim 13, characterized by the fact that the thermally conductive surface is adapted to allow cooling of the epithelium before transmitting RF energy to heat the target tissue, after transmitting RF energy to heat the target tissue, while transmits RF energy to heat the target tissue, or combinations thereof.
[0033]
33. System according to claim 13, characterized by the fact that the energy distribution element is curved.
[0034]
34. System according to claim 14, characterized by the fact that the cable is a flat cable.

类似技术:

---

公开号 | 公开日 | 专利标题

---

BR112012006059B1|2020-12-29|apparatus and system for remodeling a therapeutic zone in the tissue underlying a mucosal epithelium of female genital tissue

---

US20210228267A1|2021-07-29|Vaginal remodeling device and methods

---

TWI586314B|2017-06-11|Apparatus for remodeling a therapeutic zone within tissue underlying a mucosal epithelium of female genital tissue

同族专利:

---

公开号 | 公开日

---

CA3028905A1|2011-03-24|

---

US20160135876A1|2016-05-19|

---

KR20160092030A|2016-08-03|

---

TWI720358B|2021-03-01|

---

EP2477695A4|2013-05-29|

---

SI2477695T1|2015-12-31|

---

ES2559809T3|2016-02-16|

---

CA2774265A1|2011-03-24|

---

TW202118460A|2021-05-16|

---

CN102971047B|2016-04-06|

---

BR112012006059A2|2017-12-12|

---

US11154349B2|2021-10-26|

---

KR20180010320A|2018-01-30|

---

HK1167590A1|2012-12-07|

---

WO2011034986A3|2011-06-30|

---

HRP20160069T1|2016-02-26|

---

PT2477695E|2016-02-16|

---

JP2013505069A|2013-02-14|

---

US20200000517A1|2020-01-02|

---

DK2477695T3|2016-01-25|

---

CN102971047A|2013-03-13|

---

KR101681880B1|2016-12-12|

---

KR20160140966A|2016-12-07|

---

JP5763646B2|2015-08-12|

---

TW201902428A|2019-01-16|

---

KR102100081B1|2020-04-10|

---

CA3028905C|2021-06-01|

---

US9271785B2|2016-03-01|

---

TWI648028B|2019-01-21|

---

KR101643799B1|2016-07-28|

---

WO2011034986A2|2011-03-24|

---

US10376307B2|2019-08-13|

---

HUE026723T2|2016-09-28|

---

HK1222589A1|2017-07-07|

---

BR112012006059B8|2021-06-22|

---

CN105879238B|2019-10-18|

---

KR20190064683A|2019-06-10|

---

KR20120100921A|2012-09-12|

---

PL2477695T3|2016-03-31|

---

KR101986712B1|2019-06-07|

---

TW201720377A|2017-06-16|

---

EP2477695A2|2012-07-25|

---

CN105879238A|2016-08-24|

---

US20220022950A1|2022-01-27|

---

KR101824833B1|2018-02-01|

---

CA2774265C|2019-02-19|

---

US20110178584A1|2011-07-21|

---

EP2477695B1|2015-10-21|

---

AU2010295586A1|2012-04-12|

---

AU2010295586B2|2016-02-18|

---

IN2012DN02321A|2015-08-21|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

US2811969A|1955-10-11|1957-11-05|William M Shubert|Obstetrical instrument|

---

US3403684A|1964-11-23|1968-10-01|Ariel I. Stiebel|Electrical stimulator|

---

US3595217A|1968-05-27|1971-07-27|Robert E Rheinfrank|Fine needle aspiration biopsy of prostate|

---

US3741211A|1971-09-22|1973-06-26|W Vreeland|Finger mounted needle assembly with manifold|

---

US3995629A|1975-06-23|1976-12-07|The Kendall Company|Anesthesia device|

---

US4309989A|1976-02-09|1982-01-12|The Curators Of The University Of Missouri|Topical application of medication by ultrasound with coupling agent|

---

US4326529A|1978-05-26|1982-04-27|The United States Of America As Represented By The United States Department Of Energy|Corneal-shaping electrode|

---

US4381007A|1981-04-30|1983-04-26|The United States Of America As Represented By The United States Department Of Energy|Multipolar corneal-shaping electrode with flexible removable skirt|

---

US4454764A|1982-09-03|1984-06-19|Medtronic, Inc.|Roller-ball ultrasonic imaging module|

---

GB8420116D0|1984-08-08|1984-09-12|Elchemtec Ltd|Apparatus for monitoring redox reactions|

---

JPH0380032B2|1986-07-17|1991-12-20|Olympus Optical Co|

---

US4785828A|1986-10-06|1988-11-22|Empi, Inc.|Vaginal stimulator for controlling urinary incontinence in women|

---

US4785807B1|1987-02-24|1996-07-16|American Medical Products Inc|Electrosurgical knife|

---

US5143063A|1988-02-09|1992-09-01|Fellner Donald G|Method of removing adipose tissue from the body|

---

US4989614A|1988-02-23|1991-02-05|Vance Products Incorporated|Fine-needle aspiration cell sampling methods|

---

US4907589A|1988-04-29|1990-03-13|Cosman Eric R|Automatic over-temperature control apparatus for a therapeutic heating device|

---

US4881526A|1988-05-27|1989-11-21|Empi, Inc.|Intravaginal electrode and stimulation system for controlling female urinary incontinence|

---

US4892520A|1988-07-13|1990-01-09|Gilbaugh James H|Finger mounted surgical needle guide/needle protector|

---

US4920978A|1988-08-31|1990-05-01|Triangle Research And Development Corporation|Method and apparatus for the endoscopic treatment of deep tumors using RF hyperthermia|

---

US5230349A|1988-11-25|1993-07-27|Sensor Electronics, Inc.|Electrical heating catheter|

---

US4976709A|1988-12-15|1990-12-11|Sand Bruce J|Method for collagen treatment|

---

US5041110A|1989-07-10|1991-08-20|Beacon Laboratories, Inc.|Cart for mobilizing and interfacing use of an electrosurgical generator and inert gas supply|

---

US5010895A|1989-08-03|1991-04-30|Empi, Inc.|Expandable vaginal electrode|

---

US5046511A|1989-11-28|1991-09-10|Empi, Inc.|Vaginal electrode with snap-on electrode pad and method for preparing electrode for use|

---

US5160334A|1991-04-30|1992-11-03|Utah Medical Products, Inc.|Electrosurgical generator and suction apparatus|

---

US5242440A|1991-07-23|1993-09-07|Shippert Ronald D|Finger controlled switching apparatus|

---

US7549424B2|1991-10-18|2009-06-23|Pro Surg, Inc.|Method and apparatus for tissue treatment with laser and electromagnetic radiation|

---

US6726684B1|1996-07-16|2004-04-27|Arthrocare Corporation|Methods for electrosurgical spine surgery|

---

JP2543460B2|1992-03-23|1996-10-16|倉本工業株式会社|Fracture-percutaneous steel wire insertion guide|

---

US5443470A|1992-05-01|1995-08-22|Vesta Medical, Inc.|Method and apparatus for endometrial ablation|

---

US6419673B1|1996-05-06|2002-07-16|Stuart Edwards|Ablation of rectal and other internal body structures|

---

US5409453A|1992-08-12|1995-04-25|Vidamed, Inc.|Steerable medical probe with stylets|

---

EP0669840A4|1992-09-11|1995-11-15|Advanced Surgical Inc|Self-introducing infusion catheter.|

---

US5334193A|1992-11-13|1994-08-02|American Cardiac Ablation Co., Inc.|Fluid cooled ablation catheter|

---

US5301692A|1992-11-16|1994-04-12|Knowlton Edward W|Method for total, immediate, post-mastectomy breast reconstruction using a latissimus dorsi myocutaneous flap|

---

US5348554A|1992-12-01|1994-09-20|Cardiac Pathways Corporation|Catheter for RF ablation with cooled electrode|

---

US5697926A|1992-12-17|1997-12-16|Megadyne Medical Products, Inc.|Cautery medical instrument|

---

SE9300825D0|1993-03-12|1993-03-12|Siemens Elema Ab|DEVICE FOR Saturation of electrical activity at heart|

---

US5403311A|1993-03-29|1995-04-04|Boston Scientific Corporation|Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue|

---

US5449374A|1993-04-01|1995-09-12|University Of Massachusetts Medical Center|Tissue spreading forceps|

---

IL105626D0|1993-05-07|1993-09-22|Medispec Ltd|Heating device particularly useful for gynecological purposes|

---

CA2164860C|1993-06-10|2005-09-06|Mir A. Imran|Transurethral radio frequency ablation apparatus|

---

US5456689A|1993-10-13|1995-10-10|Arnold J. Kresch|Method and device for tissue resection|

---

US5450293A|1993-12-30|1995-09-12|Hoffman; Elliott S.|Finger mounted fiber optic illumination system|

---

JP3263275B2|1994-04-05|2002-03-04|ザリージェンツオブザユニバーシティオブカリフォルニア|Apparatus for laser treatment of living tissue and laser treatment apparatus for flame-like nevus|

---

US20050187599A1|1994-05-06|2005-08-25|Hugh Sharkey|Method and apparatus for controlled contraction of soft tissue|

---

US6277116B1|1994-05-06|2001-08-21|Vidaderm|Systems and methods for shrinking collagen in the dermis|

---

US5458596A|1994-05-06|1995-10-17|Dorsal Orthopedic Corporation|Method and apparatus for controlled contraction of soft tissue|

---

US6024743A|1994-06-24|2000-02-15|Edwards; Stuart D.|Method and apparatus for selective treatment of the uterus|

---

US6002968A|1994-06-24|1999-12-14|Vidacare, Inc.|Uterine treatment apparatus|

---

RU2125846C1|1994-09-23|1999-02-10|Московский научно-исследовательский онкологический институт им.П.А.Герцена МЗ РФ|Method for treating initial forms of cervical carcinoma|

---

US5628769A|1994-09-30|1997-05-13|Saringer Research, Inc.|Method and devices for producing somatosensory stimulation using temperature|

---

CN2223112Y|1995-01-08|1996-03-27|王共先|Intracavitary radio-frequency electrode catheter for treating cervical diseases|

---

WO1996022739A1|1995-01-24|1996-08-01|Vidamed, Inc.|Medical probe device with scope and proximal aspiraton openings and method for treatment of the prostate with same|

---

US5611798A|1995-03-02|1997-03-18|Eggers; Philip E.|Resistively heated cutting and coagulating surgical instrument|

---

US5765567A|1995-03-22|1998-06-16|Knowlton; Edward W.|Surgical method for breast reconstruction using a tissue flap|

---

US5824076A|1995-03-22|1998-10-20|Knowlton; Edward W.|Surgical method for breast reconstruction using a neovascular tissue peg|

---

US7115123B2|1996-01-05|2006-10-03|Thermage, Inc.|Handpiece with electrode and non-volatile memory|

---

US7189230B2|1996-01-05|2007-03-13|Thermage, Inc.|Method for treating skin and underlying tissue|

---

US7473251B2|1996-01-05|2009-01-06|Thermage, Inc.|Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient|

---

US5755753A|1995-05-05|1998-05-26|Thermage, Inc.|Method for controlled contraction of collagen tissue|

---

US6241753B1|1995-05-05|2001-06-05|Thermage, Inc.|Method for scar collagen formation and contraction|

---

US7267675B2|1996-01-05|2007-09-11|Thermage, Inc.|RF device with thermo-electric cooler|

---

US20040000316A1|1996-01-05|2004-01-01|Knowlton Edward W.|Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient|

---

US6350276B1|1996-01-05|2002-02-26|Thermage, Inc.|Tissue remodeling apparatus containing cooling fluid|

---

US6425912B1|1995-05-05|2002-07-30|Thermage, Inc.|Method and apparatus for modifying skin surface and soft tissue structure|

---

US7229436B2|1996-01-05|2007-06-12|Thermage, Inc.|Method and kit for treatment of tissue|

---

US20030212393A1|1996-01-05|2003-11-13|Knowlton Edward W.|Handpiece with RF electrode and non-volatile memory|

---

US6461378B1|1995-05-05|2002-10-08|Thermage, Inc.|Apparatus for smoothing contour irregularities of skin surface|

---

US7452358B2|1996-01-05|2008-11-18|Thermage, Inc.|RF electrode assembly for handpiece|

---

US7006874B2|1996-01-05|2006-02-28|Thermage, Inc.|Treatment apparatus with electromagnetic energy delivery device and non-volatile memory|

---

US5660836A|1995-05-05|1997-08-26|Knowlton; Edward W.|Method and apparatus for controlled contraction of collagen tissue|

---

US5673695A|1995-08-02|1997-10-07|Ep Technologies, Inc.|Methods for locating and ablating accessory pathways in the heart|

---

JPH09122141A|1995-10-31|1997-05-13|Semuko:Kk|Scalpel holder for electric operation apparatus|

---

JPH09140802A|1995-11-21|1997-06-03|Nippon Zeon Co Ltd|Electrode catheter|

---

CN1617689A|1999-06-30|2005-05-18|塞梅格公司|Fluid delivery apparatus|

---

CA2246332C|1996-02-15|2009-04-14|Biosense, Inc.|Catheter based surgery|

---

WO1997034534A1|1996-03-18|1997-09-25|Femrx, Inc.|Method and device for tissue vaporization and extraction|

---

US6126682A|1996-08-13|2000-10-03|Oratec Interventions, Inc.|Method for treating annular fissures in intervertebral discs|

---

US6091995A|1996-11-08|2000-07-18|Surx, Inc.|Devices, methods, and systems for shrinking tissues|

---

US20030178032A1|1997-08-13|2003-09-25|Surx, Inc.|Noninvasive devices, methods, and systems for shrinking of tissues|

---

US7317949B2|1996-11-08|2008-01-08|Ams Research Corporation|Energy induced bulking and buttressing of tissues for incontinence|

---

IT1290866B1|1996-12-24|1998-12-14|Francesco Garbagnati|PROBE-CATHETER FOR THE TREATMENT OF TUMORS OF PARENCHYMATOUS ORGANS WITH RADIOFREQUENCY INDUCED INTERSTIZIAL HYPERTHERMIA|

---

US5986446A|1997-02-05|1999-11-16|C. Blake Williamson|Multi-meter and probe assembly and method of use|

---

US5947891A|1997-04-25|1999-09-07|Morrison; Richard A.|Method and apparatus for homogeneously irradiating the vaginal mucosa with a linear source uterovaginal applicator|

---

US6081749A|1997-08-13|2000-06-27|Surx, Inc.|Noninvasive devices, methods, and systems for shrinking of tissues|

---

AT326913T|1997-08-13|2006-06-15|Solarant Medical Inc|NON-INVASIVE EQUIPMENT AND SYSTEMS FOR SHRINKING WOVEN FABRICS|

---

US6035238A|1997-08-13|2000-03-07|Surx, Inc.|Noninvasive devices, methods, and systems for shrinking of tissues|

---

US9023031B2|1997-08-13|2015-05-05|Verathon Inc.|Noninvasive devices, methods, and systems for modifying tissues|

---

US6480746B1|1997-08-13|2002-11-12|Surx, Inc.|Noninvasive devices, methods, and systems for shrinking of tissues|

---

US5957920A|1997-08-28|1999-09-28|Isothermix, Inc.|Medical instruments and techniques for treatment of urinary incontinence|

---

US6179832B1|1997-09-11|2001-01-30|Vnus Medical Technologies, Inc.|Expandable catheter having two sets of electrodes|

---

US5836990A|1997-09-19|1998-11-17|Medtronic, Inc.|Method and apparatus for determining electrode/tissue contact|

---

US5954717A|1997-09-25|1999-09-21|Radiotherapeutics Corporation|Method and system for heating solid tissue|

---

AU2318599A|1998-01-13|1999-08-02|Urometrics, Inc.|Devices and methods for monitoring female arousal|

---

US6283987B1|1998-01-14|2001-09-04|Surx, Inc.|Ribbed electrodes and methods for their use|

---

US5951550A|1998-03-11|1999-09-14|Utah Medical Products, Inc.|Endocervical conization electrode apparatus|

---

US5997534A|1998-06-08|1999-12-07|Tu; Hosheng|Medical ablation device and methods thereof|

---

US6044847A|1998-06-23|2000-04-04|Surx, Inc.|Tuck and fold fascia shortening for incontinence|

---

US6156060A|1998-07-31|2000-12-05|Surx, Inc.|Static devices and methods to shrink tissues for incontinence|

---

US6236891B1|1998-07-31|2001-05-22|Surx, Inc.|Limited heat transfer devices and methods to shrink tissues|

---

US6322584B2|1998-07-31|2001-11-27|Surx, Inc.|Temperature sensing devices and methods to shrink tissues|

---

US6139569A|1998-07-31|2000-10-31|Surx, Inc.|Interspersed heating/cooling to shrink tissues for incontinence|

---

US6572639B1|1998-07-31|2003-06-03|Surx, Inc.|Interspersed heating/cooling to shrink tissues for incontinence|

---

US7520856B2|1999-09-17|2009-04-21|University Of Washington|Image guided high intensity focused ultrasound device for therapy in obstetrics and gynecology|

---

US6461332B1|1998-10-19|2002-10-08|Surx, Inc.|Urinary incontinence diagnostic system|

---

US6416504B2|1998-10-19|2002-07-09|Surx, Inc.|Urethral catheter holder|

---

IL126723D0|1998-10-22|1999-08-17|Medoc Ltd|Vaginal probe and method|

---

US6879858B1|1998-11-25|2005-04-12|Reproductive Health Technologies, Inc.|Uterine contraction detection and initiation system and method|

---

US6427089B1|1999-02-19|2002-07-30|Edward W. Knowlton|Stomach treatment apparatus and method|

---

US7022121B2|1999-03-09|2006-04-04|Thermage, Inc.|Handpiece for treatment of tissue|

---

US7141049B2|1999-03-09|2006-11-28|Thermage, Inc.|Handpiece for treatment of tissue|

---

DE60021063T2|1999-03-09|2006-05-11|Thermage, Inc., Hayward|TREATMENT FOR TREATMENT OF TISSUE|

---

US20020156471A1|1999-03-09|2002-10-24|Stern Roger A.|Method for treatment of tissue|

---

US6463331B1|1999-04-19|2002-10-08|Novasys Medical, Inc.|Application of energy and substances in the treatment of uro-genital disorders|

---

US6692490B1|1999-05-18|2004-02-17|Novasys Medical, Inc.|Treatment of urinary incontinence and other disorders by application of energy and drugs|

---

US6292700B1|1999-09-10|2001-09-18|Surx, Inc.|Endopelvic fascia treatment for incontinence|

---

US6629974B2|2000-02-22|2003-10-07|Gyrus Medical Limited|Tissue treatment method|

---

US6569160B1|2000-07-07|2003-05-27|Biosense, Inc.|System and method for detecting electrode-tissue contact|

---

AU7976401A|2000-07-24|2002-02-05|Michael Nordmann|Device for heat treatment of the vaginal or colonic region|

---

US6494882B1|2000-07-25|2002-12-17|Verimetra, Inc.|Cutting instrument having integrated sensors|

---

US6418930B1|2000-11-14|2002-07-16|Mayo Foundation For Medical Education And Research|Anatomic incontinence pessary|

---

US7785323B2|2000-12-04|2010-08-31|Boston Scientific Scimed, Inc.|Loop structure including inflatable therapeutic device|

---

US6432105B1|2000-12-04|2002-08-13|Alan G. Ellman|Bipolar electrosurgical handpiece for treating tissue|

---

CN2454769Y|2000-12-14|2001-10-17|中国科学院低温技术实验中心|Multi-point temp. detection device for on-body detection of local metabolic-rate of biologic live tissue|

---

US20020087151A1|2000-12-29|2002-07-04|Afx, Inc.|Tissue ablation apparatus with a sliding ablation instrument and method|

---

JP2002238919A|2001-02-20|2002-08-27|Olympus Optical Co Ltd|Control apparatus for medical care system and medical care system|

---

US7422586B2|2001-02-28|2008-09-09|Angiodynamics, Inc.|Tissue surface treatment apparatus and method|

---

US6607525B2|2001-08-01|2003-08-19|Nicolas Franco|Apparatus and method for treating urinary stress incontinence|

---

US6652514B2|2001-09-13|2003-11-25|Alan G. Ellman|Intelligent selection system for electrosurgical instrument|

---

CA2461217A1|2001-09-27|2003-04-03|Roni Zvuloni|Cryoplasty apparatus and method|

---

US6830052B2|2001-10-03|2004-12-14|Solarant Medical, Inc.|Urethral support for incontinence|

---

US6889090B2|2001-11-20|2005-05-03|Syneron Medical Ltd.|System and method for skin treatment using electrical current|

---

US20060205996A1|2001-11-20|2006-09-14|Solorant Medical, Inc.|Incontinence treatment with urethral guide|

---

US7179219B2|2001-11-20|2007-02-20|Ams Research Corporation|Incontinence treatment with urethral guide|

---

US6685623B2|2001-11-20|2004-02-03|Surx, Inc.|Incontinence treatment with urethral guide|

---

US6840954B2|2001-12-20|2005-01-11|Solarant Medical, Inc.|Systems and methods using vasoconstriction for improved thermal treatment of tissues|

---

US20030119209A1|2001-12-21|2003-06-26|Kaylor Rosann Marie|Diagnostic methods and devices|

---

US20030139740A1|2002-01-22|2003-07-24|Syneron Medical Ltd.|System and method for treating skin|

---

US7294127B2|2002-03-05|2007-11-13|Baylis Medical Company Inc.|Electrosurgical tissue treatment method|

---

US6882885B2|2002-03-19|2005-04-19|Solarant Medical, Inc.|Heating method for tissue contraction|

---

US6681771B2|2002-03-22|2004-01-27|Jean-Francois Durette|Organ shields for medical procedures|

---

RU2217186C1|2002-04-09|2003-11-27|Государственное образовательное учреждение высшего профессионального образования "Пермская государственная медицинская академия"|Method for treating benign diseases of uterine cervix|

---

US20030236487A1|2002-04-29|2003-12-25|Knowlton Edward W.|Method for treatment of tissue with feedback|

---

US7967839B2|2002-05-20|2011-06-28|Rocky Mountain Biosystems, Inc.|Electromagnetic treatment of tissues and cells|

---

US20040127895A1|2002-05-20|2004-07-01|Flock Stephen T.|Electromagnetic treatment of tissues and cells|

---

WO2003099102A2|2002-05-20|2003-12-04|Kevin Marchitto|Device and method for wound healing and uses therefor|

---

US7442192B2|2002-07-14|2008-10-28|Knowlton Edward W|Method and apparatus for surgical dissection|

---

US20040172291A1|2002-07-25|2004-09-02|Knowlton Edward W.|System and methods for medical services and transactions|

---

US6852110B2|2002-08-01|2005-02-08|Solarant Medical, Inc.|Needle deployment for temperature sensing from an electrode|

---

US20040260281A1|2002-09-19|2004-12-23|Baxter Chester O.|Finger tip electrosurgical medical device|

---

EP1613229A2|2002-12-20|2006-01-11|Manoa Medical, Inc.|Systems and methods for cutting tissue|

---

WO2004064599A2|2003-01-16|2004-08-05|Solarant Medical, Inc.|Non-surgical incontinence treatment system andmethod|

---

US9149322B2|2003-03-31|2015-10-06|Edward Wells Knowlton|Method for treatment of tissue|

---

US20040206365A1|2003-03-31|2004-10-21|Knowlton Edward Wells|Method for treatment of tissue|

---

US7282060B2|2003-12-23|2007-10-16|Reliant Technologies, Inc.|Method and apparatus for monitoring and controlling laser-induced tissue treatment|

---

JP2005198896A|2004-01-16|2005-07-28|Olympus Corp|Medical treatment instrument|

---

US7251531B2|2004-01-30|2007-07-31|Ams Research Corporation|Heating method for tissue contraction|

---

US7476242B2|2004-01-30|2009-01-13|Ams Research Corporation|Electrically heated/phase change probe temperature control|

---

JP3607911B1|2004-05-06|2005-01-05|株式会社ティグレ・タクミ|Ovulation detector|

---

US20060064009A1|2004-09-21|2006-03-23|Webler William E|Vessel imaging devices and methods|

---

JP4848373B2|2004-09-23|2011-12-28|スパインソルーションズインコーポレイテッド|Test implant, device and method for preparing an intervertebral space|

---

US20120016239A1|2004-10-06|2012-01-19|Guided Therapy Systems, Llc|Systems for cosmetic treatment|

---

CN1778414A|2004-11-18|2006-05-31|田中枢|Multifunctional supersonic gynopathic therapeutic equipment|

---

US8262715B2|2004-11-23|2012-09-11|Eye Delivery System, Llc|Medical device and method for temperature control and treatment of the eye and surrounding tissues via magnetic drug therapy|

---

JP4979019B2|2005-01-18|2012-07-18|アルマレーザーズエルティディ．|Improved system and method for biological tissue heating using RF energy|

---

US7536225B2|2005-01-21|2009-05-19|Ams Research Corporation|Endo-pelvic fascia penetrating heating systems and methods for incontinence treatment|

---

WO2006105121A2|2005-03-28|2006-10-05|Minnow Medical, Llc|Intraluminal electrical tissue characterization and tuned rf energy for selective treatment of atheroma and other target tissues|

---

US20060224090A1|2005-03-29|2006-10-05|Isaac Ostrovsky|Apparatus and method for stiffening tissue|

---

CA2602835A1|2005-03-31|2006-10-05|Esther Mayer|Probe device, system and method for photobiomodulation of tissue lining a body cavity|

---

US7837682B2|2005-04-04|2010-11-23|Boston Scientific Scimed, Inc.|Device and method for positioning of a therapeutic device|

---

US9623265B2|2005-04-07|2017-04-18|Boston Scientific Scimed, Inc.|Device for controlled tissue treatment|

---

WO2006122156A2|2005-05-09|2006-11-16|Hydra Biosciences, Inc.|Compounds for modulating trpv3 function|

---

US7713266B2|2005-05-20|2010-05-11|Myoscience, Inc.|Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue |

---

US7850683B2|2005-05-20|2010-12-14|Myoscience, Inc.|Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue |

---

CN1868396A|2005-05-27|2006-11-29|上海飞恩微电子有限公司|Medicine-releasing type capsule endoscope|

---

US9016431B2|2005-06-03|2015-04-28|Great Trango Holdings, Inc.|Load balancing descending device|

---

US7955262B2|2005-07-26|2011-06-07|Syneron Medical Ltd.|Method and apparatus for treatment of skin using RF and ultrasound energies|

---

RU2291673C1|2005-08-09|2007-01-20|Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Федерального Агентства по здравоохранению и социальному развитию" |Method for applying cryogenic therapy to treat uterine cervix diseases|

---

US20070078502A1|2005-10-05|2007-04-05|Thermage, Inc.|Method and apparatus for estimating a local impedance factor|

---

US7957815B2|2005-10-11|2011-06-07|Thermage, Inc.|Electrode assembly and handpiece with adjustable system impedance, and methods of operating an energy-based medical system to treat tissue|

---

US8702691B2|2005-10-19|2014-04-22|Thermage, Inc.|Treatment apparatus and methods for delivering energy at multiple selectable depths in tissue|

---

US8603084B2|2005-12-06|2013-12-10|St. Jude Medical, Atrial Fibrillation Division, Inc.|System and method for assessing the formation of a lesion in tissue|

---

US8961511B2|2006-02-07|2015-02-24|Viveve, Inc.|Vaginal remodeling device and methods|

---

TWI288637B|2006-02-20|2007-10-21|Bion Inc|Apparatus for shaping breast|

---

US9675821B2|2006-03-14|2017-06-13|Boston Scientific Scimed, Inc.|Device for thermal treatment of tissue and for temperature measurement of tissue providing feedback|

---

CN2885157Y|2006-03-23|2007-04-04|迈德医疗科技（上海）有限公司|Perfuseable probe electrode|

---

CN2897183Y|2006-03-30|2007-05-09|迈德医疗科技（上海）有限公司|Blunt probe electrode device|

---

JP4679416B2|2006-04-10|2011-04-27|オリンパス株式会社|Surgical device|

---

TWI314449B|2006-08-14|2009-09-11|Nat Univ Tsing Hua|Biopolymer-bioengineered cell sheet construct for tissue reconstruction and method for making an implant for reconstructing corneal endothelium in a patient|

---

US8317782B1|2006-10-13|2012-11-27|Ellman International, Inc.|Non-ablative radio-frequency treatment of skin tissue|

---

US9492686B2|2006-12-04|2016-11-15|Koninklijke Philips N.V.|Devices and methods for treatment of skin conditions|

---

US9254162B2|2006-12-21|2016-02-09|Myoscience, Inc.|Dermal and transdermal cryogenic microprobe systems|

---

US20080200969A1|2007-02-16|2008-08-21|Thermage, Inc.|Temperature sensing apparatus and methods for treatment devices used to deliver high frequency energy to tissue|

---

US8409185B2|2007-02-16|2013-04-02|Myoscience, Inc.|Replaceable and/or easily removable needle systems for dermal and transdermal cryogenic remodeling|

---

JP4928322B2|2007-03-27|2012-05-09|富士フイルム株式会社|Electronic endoscope device|

---

EP2155100A4|2007-06-08|2013-11-06|Cynosure Inc|Thermal surgery safety suite|

---

CN101854977B|2007-09-14|2015-09-09|拉热尔技术有限公司|Prostate cancer ablation|

---

CN101229078A|2007-11-28|2008-07-30|郁如煌|Hand-held multifunctional combined cryo-therapeutic device|

---

TWI453048B|2007-12-07|2014-09-21|Gen Hospital Corp|Apparatus for applying optical radiation to biological tissue|

---

US8177825B2|2007-12-10|2012-05-15|Remco International, Inc.|Method of dynamic binary temperature therapy|

---

US20090163807A1|2007-12-21|2009-06-25|Sliwa John W|Finger-mounted or robot-mounted transducer device|

---

US8515553B2|2008-04-28|2013-08-20|Thermage, Inc.|Methods and apparatus for predictively controlling the temperature of a coolant delivered to a treatment device|

---

US8206385B2|2008-06-09|2012-06-26|St. Jude Medical, Atrial Fibrillation Division, Inc.|Catheter assembly with front-loaded tip and multi-contact connector|

---

US8285392B2|2008-06-19|2012-10-09|Thermage, Inc.|Leakage-resistant tissue treatment apparatus and methods of using such tissue treatment apparatus|

---

US8121704B2|2008-06-19|2012-02-21|Thermage, Inc.|Leakage-resistant tissue treatment apparatus and methods of using same|

---

CN201286935Y|2008-10-19|2009-08-12|邵秀芹|Novel gynecology-department administration device|

---

US9980774B2|2008-10-21|2018-05-29|Microcube, Llc|Methods and devices for delivering microwave energy|

---

AU2009330022B2|2008-12-22|2015-04-09|Myoscience, Inc.|Skin protection for subdermal cryogenic remodeling for cosmetic and other treatments|

---

US8882758B2|2009-01-09|2014-11-11|Solta Medical, Inc.|Tissue treatment apparatus and systems with pain mitigation and methods for mitigating pain during tissue treatments|

---

KR101182880B1|2009-01-28|2012-09-13|삼성메디슨 주식회사|Ultrasound system and method for providing image indicator|

---

CN101810505B|2009-02-19|2012-12-26|金华职业技术学院|Portable safe cervical therapy apparatus|

---

US8788060B2|2009-07-16|2014-07-22|Solta Medical, Inc.|Tissue treatment systems with high powered functional electrical stimulation and methods for reducing pain during tissue treatments|

---

BR112012006059B8|2009-09-18|2021-06-22|Viveve Inc|apparatus and system for remodeling a therapeutic zone in the tissue underlying a mucosal epithelium of female genital tissue|

---

US9474565B2|2009-09-22|2016-10-25|Mederi Therapeutics, Inc.|Systems and methods for treating tissue with radiofrequency energy|

---

CA2778960C|2009-10-26|2016-04-26|Biolase Technology, Inc.|High power radiation source with active-media housing|

---

US9039698B2|2009-11-30|2015-05-26|Medwaves, Inc.|Radio frequency ablation system with tracking sensor|

---

US20110202108A1|2010-02-18|2011-08-18|Rainbow Medical Ltd.|Electrical menorrhagia treatment|

---

US20120089211A1|2010-04-08|2012-04-12|Myoscience, Inc.|Methods and apparatus for cryogenically treating multiple tissue sites with a single puncture|

---

CA2803613C|2010-06-29|2018-12-11|Cv Holdings, Llc|Syringe with integrated needle|

---

KR101159452B1|2010-07-27|2012-06-25|주성대학산학협력단|Ultrasonic treatment apparatus|

---

US9028484B2|2010-11-16|2015-05-12|Covidien Lp|Fingertip electrosurgical instruments for use in hand-assisted surgery and systems including same|

---

ES2440795T3|2011-01-12|2014-01-30|Fotona D.D.|Laser system for non-ablative treatment of mucosal tissues|

---

US8475507B2|2011-02-01|2013-07-02|Solta Medical, Inc.|Handheld apparatus for use by a non-physician consumer to fractionally resurface the skin of the consumer|

---

US20120239122A1|2011-03-17|2012-09-20|Rong Dong|Apparatus and method for hot-cold contrast therapy|

---

AU2012286770B2|2011-07-26|2016-01-07|Hologic, Inc.|Apparatus and methods to modulate pelvic nervous tissue|

---

US9907612B2|2011-09-06|2018-03-06|Solta Medical, Inc.|Cooled medical handpiece|

---

KR102087894B1|2011-11-16|2020-03-12|더 제너럴 하스피탈 코포레이션|Method and apparatus for cryogenic treatment of skin tissue|

---

WO2013106859A1|2012-01-13|2013-07-18|Myoscience, Inc.|Cryogenic needle with freeze zone regulation|

---

EP2802280B1|2012-01-13|2016-11-30|Myoscience, Inc.|Skin protection for subdermal cryogenic remodeling for cosmetic and other treatments|

---

CN103300961B|2012-03-16|2016-10-26|女康乐公司|A kind of therapeutic apparatus repairing vagina tissue with direction inductor device or sounding mark|

---

CN202859437U|2012-03-16|2013-04-10|女康乐公司|Treatment device for repairing female vaginal tissue|

---

CN202724094U|2012-03-16|2013-02-13|女康乐公司|Therapeutic equipment capable of repairing female vagina organization with temperature sensor|

---

CN103301567B|2012-03-16|2016-04-06|女康乐公司|A kind of therapeutic apparatus repairing vagina tissue|

---

CN202751492U|2012-03-16|2013-02-27|女康乐公司|Vaginal tissue repair curer equipped with direction sensors|

---

WO2014004922A1|2012-06-27|2014-01-03|The Regents Of The University Of California|Apparatus and methods for transurethral treatment of stress urinary incontinence|

---

US10307620B2|2012-06-27|2019-06-04|Acoustic Medsystems, Inc.|Noninvasive transvaginal acoustic thermal treatment of female stress urinary incontinence|

---

US20140148878A1|2012-11-29|2014-05-29|Khalilullah A. Khatri|Non-surgical method for tightening both external pubic and internal vaginal tissues in a single procedure|

---

US9161802B2|2013-01-03|2015-10-20|Solta Medical, Inc.|Patterned electrodes for tissue treatment systems|

---

CN104027893B|2013-03-08|2021-08-31|奥赛拉公司|Apparatus and method for multi-focal ultrasound therapy|

---

WO2014165242A1|2013-03-12|2014-10-09|Acoustic Medsystems, Inc.|Ultrasound therapy cathether with multi-chambered balloons for transluminal longitudinal positioning|

---

ES2533145B1|2013-10-03|2016-07-12|Clinipro, S. L.|COSMETIC PROCEDURE TO REDUCE SUBCUTANEOUS ADIPOSE TISSUE|

---

US9949889B2|2013-11-11|2018-04-24|Joylux, Inc.|At-home light-emitting diode and massage device for vaginal rejuvenation|

---

DE202014100400U1|2014-01-30|2014-02-13|Seb S.A.|Apparatus for treating the skin with a tactile guide|

---

US10201380B2|2014-01-31|2019-02-12|Zeltiq Aesthetics, Inc.|Treatment systems, methods, and apparatuses for improving the appearance of skin and providing other treatments|

---

JP2017513587A|2014-04-18|2017-06-01|ウルセラ インコーポレイテッド|Band transducer ultrasound therapy|

---

US20150297908A1|2014-04-22|2015-10-22|ThermiGen, LLC|Methods and radiofrequency treatment probe for treating vaginal laxity|

---

US9713565B2|2014-06-20|2017-07-25|Chongqing Peninsula Medical Technology Co., Ltd.|Virginal rejuvenation apparatus and method|

---

WO2016004295A1|2014-07-02|2016-01-07|Diller Kenneth R|Cryotherapy devices and methods with alternating cooling and heating to limit ischemic injury and to enhance wound healing|

---

JP6682539B2|2014-12-19|2020-04-15|ハイロニック コーポレーション リミテッドＨｉｒｏｎｉｃ Ｃｏ．，Ｌｔｄ．|Focused ultrasonic treatment device|

---

US10779874B2|2015-09-16|2020-09-22|Viveve, Inc.|Methods and systems for treating urinary stress incontinence|

---

IL251463D0|2016-03-30|2017-06-29|Alma Lasers Ltd|Laser treatment device and method|US8961511B2|2006-02-07|2015-02-24|Viveve, Inc.|Vaginal remodeling device and methods|

---

EP3481495A4|2016-07-07|2020-04-29|Venus Concept Ltd|An esthetic apparatus useful for increasing skin rejuvenation and methods thereof|

---

BR112012006059B8|2009-09-18|2021-06-22|Viveve Inc|apparatus and system for remodeling a therapeutic zone in the tissue underlying a mucosal epithelium of female genital tissue|

---

IT1405000B1|2010-02-04|2013-12-16|El En Spa|DEVICE FOR THE TREATMENT OF THE VAGINAL CHANNEL AND ITS APPARATUS|

---

WO2013055815A1|2011-10-11|2013-04-18|Boston Scientific Scimed, Inc.|Off -wall electrode device for nerve modulation|

---

CN103300961B|2012-03-16|2016-10-26|女康乐公司|A kind of therapeutic apparatus repairing vagina tissue with direction inductor device or sounding mark|

---

CN108744289A|2012-03-16|2018-11-06|女康乐公司|A kind of therapeutic equipment of the reparation vagina tissue with temperature inductor or sounding mark|

---

CN107616870A|2012-03-16|2018-01-23|女康乐公司|A kind of therapeutic equipment for repairing vagina tissue|

---

CN103301567B|2012-03-16|2016-04-06|女康乐公司|A kind of therapeutic apparatus repairing vagina tissue|

---

ES2453445B2|2012-09-06|2015-01-20|María Del Pilar SÁNCHEZ JAIME|Intracavitary element|

---

US10143831B2|2013-03-14|2018-12-04|Cynosure, Inc.|Electrosurgical systems and methods|

---

WO2014159446A1|2013-03-14|2014-10-02|Ellman In Ternational, Inc.|Electrosurgical systems|

---

EP2967711B1|2013-03-15|2020-05-06|Cynosure, LLC|Electrosurgical instruments with multimodes of operation|

---

US9949889B2|2013-11-11|2018-04-24|Joylux, Inc.|At-home light-emitting diode and massage device for vaginal rejuvenation|

---

CN104013467B|2014-06-20|2016-12-14|重庆德马光电技术有限公司|The radio-frequency therapeutic equipment compacted for vaginal orifice|

---

US9713565B2|2014-06-20|2017-07-25|Chongqing Peninsula Medical Technology Co., Ltd.|Virginal rejuvenation apparatus and method|

---

JP6682539B2|2014-12-19|2020-04-15|ハイロニック コーポレーション リミテッドＨｉｒｏｎｉｃ Ｃｏ．，Ｌｔｄ．|Focused ultrasonic treatment device|

---

WO2017042737A1|2015-09-11|2017-03-16|Novavision Group S.P.A.|Handle assembly for radio frequency therapy|

---

US10779874B2|2015-09-16|2020-09-22|Viveve, Inc.|Methods and systems for treating urinary stress incontinence|

---

US10179085B2|2015-10-02|2019-01-15|Joylux, Inc.|Light-emitting diode and massage device for delivering focused light for vaginal rejuvenation|

---

CN109843202A|2016-07-01|2019-06-04|赛诺秀有限责任公司|Noninvasive, uniform non-homogeneous RF method and system related application|

---

IT201600073116A1|2016-07-13|2018-01-13|Venus Concept Ltd|A USEFUL AESTHETIC DEVICE TO INCREASE THE REJUVENATION OF A MUCOSA FABRIC|

---

CN106308825A|2016-08-24|2017-01-11|宇龙计算机通信科技有限公司|Pelvic floor muscle data processing method and device|

---

WO2018213754A1|2017-05-19|2018-11-22|Viveve, Inc.|System for endovaginal delivery of therapeutic energies|

---

JP2021503359A|2017-11-17|2021-02-12|シェリー トーマス，|Treatment methods and devices for female urinary incontinence and fecal incontinence|

---

EP3870085A1|2018-10-23|2021-09-01|Taras S.r.l.|Handpiece for intraorifice radiofrequency treatments|

---

KR102233949B1|2018-11-16|2021-03-31|주식회사 루트로닉|Energy transfer module for a vagina wall treatment device, control method of a vagina wall treatment device comprising that|

---

CN111821017A|2019-07-22|2020-10-27|南阳市中心医院|Microwave therapeutic device for uterine cavity|

---

CN112386811B|2021-01-19|2021-04-09|武汉亚格光电技术股份有限公司|Cooling type photodynamic therapy apparatus for intracavity therapy|

法律状态:
2019-01-08| B06F| Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]|

---

2019-07-23| B06U| Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]|

---

2020-09-24| B09A| Decision: intention to grant [chapter 9.1 patent gazette]|

---

2020-12-29| B16A| Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]|Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/12/2020, OBSERVADAS AS CONDICOES LEGAIS. |

---

2021-04-13| B16C| Correction of notification of the grant [chapter 16.3 patent gazette]|Free format text: REF. RPI 2608 DE 29/12/2020 QUANTO AO INVENTOR. |

---

2021-06-22| B16C| Correction of notification of the grant [chapter 16.3 patent gazette]|Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/09/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO |

优先权:

---

申请号 | 申请日 | 专利标题

---

US24368609P| true| 2009-09-18|2009-09-18|

---

US61/243,686|2009-09-18|

---

PCT/US2010/049045|WO2011034986A2|2009-09-18|2010-09-16|Vaginal remodeling device and methods|

---